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ABSTRACT
Skeletal muscle comprises approximately 30% of total body mass, and loss of muscle mass and
dysfunctional muscle metabolism are implicated in multiple disease states, including type 2
diabetes, heart failure, and septic shock. As such, understanding the mechanisms of skeletal
muscle growth and atrophy, including pharmaceutical targets that may prove safe and effective,
is therefore an important goal of current research on skeletal muscle physiology. One potential
target in skeletal muscle development and function that has not been fully explored is the Na/KATPase (NKA), especially the α1 isoform. This isoform has a unique signaling function that has
previously been shown to regulate growth, metabolism, and organogenesis and comprises only
10% of the total NKA in skeletal muscle. We therefore investigated the role of this signaling
isoform in skeletal muscle. To accomplish this, we utilized a global NKA α1 haplodeficient
mouse (α1+/-). The oxidative soleus muscles of skα1+/- were 10% smaller than controls, while
the glycolytic extensor digitorum longus mass was unchanged. This prompted us to analyze the
metabolism of cells lacking NKA α1, which revealed that the α1 isoform is necessary for
metabolic reserve and flexibility. A second mouse model was generated with a skeletal musclespecific ablation of NKA α1. These mice had a 35% reduction in skeletal muscle mass and a
switch from oxidative to glycolytic fibers. Paradoxically, these mice were protected from dietinduced metabolic dysfunction including diet-induced insulin resistance. This provided the first
genetic in vivo model of α1 signaling as a major regulator of metabolism and led to the
hypothesis that the evolution of the Src binding sites in α1 in mammals may be linked to the
development of increased metabolic reserve associated with the evolution of endothermy. These
findings together confirm a vital role of NKA α1 in skeletal muscle development and
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metabolism, and link the evolution of endothermy to the evolution of the NKA α1 Src binding
sites.

xi

CHAPTER 1
INTRODUCTION
Skeletal muscle is the largest organ in the body, on average comprising between 31% and
38% of total body mass (Janssen, Heymsfield, Wang, & Ross, 2000). Furthermore, skeletal
muscle accounts for an estimated 20-30% of metabolic flux at rest (Zurlo, Larson, Bogardus, &
Ravussin, 1990), and is the tissue most responsive to insulin-stimulated glucose uptake (Honka
et al., 2018), even when normalized to organ mass. Dysregulation of insulin signaling in skeletal
muscle is sufficient to cause whole-body insulin resistance (DeFronzo & Tripathy, 2009), and
muscle mass can largely predict a person’s susceptibility to diabetes (Son et al., 2017).
Therefore, understanding the mechanisms which regulate skeletal muscle metabolism and
growth are key to treating the growing global health concerns of obesity and insulin resistance,
which affect 13% and 8.5% of adults worldwide, respectively (Collaboration, 2016, 2017).
In addition to its role in metabolic regulation, skeletal muscle is vital for normal function
and movement. Skeletal muscle atrophy due to aging (sarcopenia), cancer (cachexia), or disuse
due to injury or bedrest impacts large numbers of people each year and currently has no
approved treatment options besides physical therapy and exercise (Dhillon & Hasni, 2017;
Sakuma, Aoi, & Yamaguchi, 2017; Theilen, Kunkel, & Tyagi, 2017; Weihrauch & Handschin,
2018). These changes in muscle mass can have long-term impacts on patient outcomes, with
higher muscle mass associated with better outcomes (Ishizu et al., 2017; Moorthi & Avin, 2017).
Understanding the mechanisms of skeletal muscle growth and atrophy, including pharmaceutical
targets that may prove safe and effective, is therefore an important goal of current research on
skeletal muscle physiology.
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One potential target in skeletal muscle development and function that has not been fully
explored is the Na/K-ATPase (NKA), especially the α1 isoform. Although the oldest-known
function of NKA is the active transport of Na+ and K+ across the cell membrane to create a
membrane potential, the α1 isoform has a more recently discovered signaling function (Cui &
Xie, 2017; Pierre & Xie, 2006; Z. Xie & Askari, 2002). These studies have linked NKA α1
signaling to the regulation of such vital processes as mitochondrial reactive oxygen species
(ROS) production (Yan et al., 2013), cell metabolism (Banerjee et al., 2018), cell proliferation
(Lai et al., 2013; Liang, Cai, Tian, Qu, & Xie, 2006; Tian et al., 2009; Ye et al., 2013), and
organogenesis (Fontana, Burlaka, Khodus, Brismar, & Aperia, 2013; Khodus, Kruusmagi, Li,
Liu, & Aperia, 2011; J. Li et al., 2010; X. Wang et al., 2019). The signaling NKA α1 isoform has
not been studied extensively in skeletal muscle, as it represents only about 13% of the total NKA
in skeletal muscle (He et al., 2001). Considering the importance of skeletal muscle metabolism
and growth regulation in human health and disease, we explored the potential role of NKA α1 as
a regulator of skeletal muscle growth and metabolism.
Molecular Properties of Na/K-ATPase Isoforms in the Skeletal Muscle
Na/K-ATPase as an Ion Pump
The Na/K-ATPase (NKA) is a P-type ATPase which transfers both Na+ and K+ across the
cell membrane against their concentration gradients to generate a membrane potential and
maintain cell volume (Blanco, 2005a; Skou & Esmann, 1992). As a P-type ATPase, NKA
hydrolyzes ATP, phosphorylating the aspartate residue at position 369 on the third cytoplasmic
domain of the catalytic α subunit (indicated by a star in Figure 2) (Kuntzweiler, Wallick,
Johnson, & Lingrel, 1995). NKA undergoes conformational changes between the E1 and E2
states to transport K+ out of and Na+ into the cells. These conformational changes were first
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described by Siegel and Albers in 1967 and refined by Post et al. in 1969 and are known as the
Albers-Post mechanism (Figure 1), which allows the active transport of Na+ and K+ out of and
into the cell, thereby maintaining the electrochemical gradient (Post, Kume, Tobin, Orcutt, &
Sen, 1969; Siegel & Albers, 1967). Since the discovery of NKA by Jens Skou in 1957 (Skou,
1957), its role as an ion pump in a variety of tissues has been the focus of many studies (Blanco,
2005a; Cougnon, Moseley, Radzyukevich, Lingrel, & Heiny, 2002; Gerbi et al., 1998; He et al.,
2001; P. F. James et al., 1999; Thompson & McDonough, 1996).
α
Isoform

Tissue Distribution

Associated Na+ Affinity
β Isoform
(K0.5, mM)

K+ Affinity
(K0.5, mM)

Ouabain Inhibition
(Ki, M)

Ouabain Affinity
(Kd, M)

Species

16.4 ± 0.7

1.9 ± 0.2

4.3±1.9×10-5

N/A

Rat

8.3 ± 0.6

0.92 ± 0.11

2.0±0.6×10-7

N/A

Human
Human

β1
α1

α2

Ubiquitous

Myofibers,
cardiomyocytes,
glial cells, smooth
muscle, adipose
tissue

β2

N/A

1.16 ± 0.02

N/A

1.98±0.21×10-8

β3

N/A

1.05 ± 0.12

N/A

1.91±0.20×10-8

Human

12.4 ± 0.5

3.6 ± 0.3

1.7±0.1×10-7

N/A

Rat

12.8 ± 2.2

1.30 ± 0.17

β1

β2
β3
β1

α3

Neurons

β2
β3
β1

α4

Sperm
β3

N/A

Kinetics Source
(Blanco, Koster, Sanchez, &
Mercer, 1995; Blanco, Sanchez,
& Mercer, 1995)
(Sanchez, Nguyen, Timmerberg,
Tash, & Blanco, 2006)
(G. Crambert et al., 2000)
(G. Crambert et al., 2000)
(Blanco, Koster, et al., 1995;
Blanco, Sanchez, et al., 1995)
(G. Crambert et al., 2000)

3.69±0.31×10-8

Human

N/A

Rat

(Blanco, Koster, et al., 1995;
Blanco, Sanchez, et al., 1995)
(G. Crambert et al., 2000)

8.8 ± 1.0

4.8 ± 0.4

1.5±0.2×10-7

N/A

2.70 ± 0.3

N/A

2.65±0.65×10-8

Human

N/A

1.80 ± 0.10

N/A

2.90±0.65×10-8

Human

(G. Crambert et al., 2000)

27.9 ± 1.3

5.3 ± 0.3

3.1±0.3×10-8

N/A

Rat

(Blanco, Sanchez, et al., 1995)

24.7 ± 2.4

0.90 ± 0.27

N/A

1.43±0.08×10-8

Human

(G. Crambert et al., 2000)

17.1 ± 1.0

6.2 ± 0.4

4.7±0.4×10-8

N/A

Rat

(Blanco, Sanchez, et al., 1995)

N/A

1.60 ± 0.10

N/A

1.76±0.20×10-8

Human

(G. Crambert et al., 2000)

N/A

1.33 ± 0.17

N/A

1.25±0.20×10-8

Human

(G. Crambert et al., 2000)

N/A

N/A

1.0±0.3×10-8

N/A

Human

(Sanchez et al., 2006)

5.9 ± 1.1

6.4±2.1×10-9

N/A

Rat

(Blanco, Melton, Sanchez, &
Mercer, 1999)

N/A

N/A

1.8±0.7×10-8

N/A

Human

(Sanchez et al., 2006)

12.9 ± 0.6

5.0 ± 0.3

1.0±0.3×10-8

N/A

Rat

(Blanco et al., 1999)

13.5 ± 1.3

Table 1: NKA α isoform enzymatic properties
List of human and rat NKA α isoforms affinities for Na+ and K+ (K0.5) and inhibitor constants
(Ki) or affinities (Kd) for ouabain, depending on study design.
NKA is comprised of a catalytic α subunit, a targeting β subunit, and in some tissues, a
regulatory γ or FXYD subunit (Figure 1) (Blanco, 2005a). The α subunit is necessary for the
transport of Na+ and K+ (Blanco, DeTomaso, Koster, Xie, & Mercer, 1994), while the β subunit
is required for normal trafficking and to stabilize the α subunit, usually by targeting the α1
3

subunit to the plasma membrane and thereby preventing degradation (Geering et al., 1996). The
γ subunit is expressed in a tissue-specific manner and can bind the catalytic α subunit at
transmembrane segments 2 and 9 (see Figure 2). This association of the γ subunit with the
functional αβ complex leads to decreased substrate affinity and thereby decreased ion transport
activity (Gilles Crambert, Füzesi, Garty, Karlish, & Geering, 2002; G. Crambert et al., 2000).
This inhibitory function is partially regulated by phosphorylation in at least some γ isoforms
(Gilles Crambert et al., 2002; G. Crambert et al., 2000; Manoharan et al., 2015).

Figure 1: NKA subunits and Albers-Post mechanism
Schematic of the Albers-Post mechanism of NKA active Na and K and general structural
representation of the catalytic α, targeting β, and regulatory γ subunit.
Four isoforms of the catalytic α subunit have been identified in mammals, with a tissuespecific distribution (Blanco, 2005a; Young & Lingrel, 1987). These isoforms differ slightly in
enzymatic function, with decreased Na+ affinity in the α3 isoform and decreased K+ affinity in
the α2 isoform (Blanco, Koster, et al., 1995; Blanco, Sanchez, et al., 1995; G. Crambert et al.,
2000; Jewell & Lingrel, 1991; Sanchez et al., 2006), two isoforms found in excitable tissues
(Table 1). While ouabain binding affinity is similar among most mammalian isoforms, with
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inhibitor constants (Ki) ranging from the 10-100 nM range (Table 1), the alteration of two amino
acids on the second extracellular loop in rat and mouse α1 (L111R and N122D, positions
indicated by red circles in Figure 2) decreases the binding affinity of cardiotonic steroids by two
orders of magnitude, to a Ki of 43 µM (Blanco, Koster, et al., 1995; Blanco, Sanchez, et al.,
1995; Blanco, Xie, & Mercer, 1993; Dostanic et al., 2003). This difference has been proposed to
alter calcium signaling and muscle fatigue (Despa, Lingrel, & Bers, 2012; Radzyukevich,
Lingrel, & Heiny, 2009). While some have proposed that the tissue-specific distribution of these
different α isoforms may be related to differences in enzymatic activities (Blanco, 2005a,
2005b), these differences do not fully explain the distribution of α isoforms and the possibility
that the tissue distribution may be related to other functions of NKA. For example, while
excitable tissues such as skeletal muscle and neurons express multiple α isoforms, the α2 isoform
is also expressed in adipocytes, which are not electrically excitable (Orlowski & Lingrel, 1988b).
Additionally, although skeletal muscle contains both α1 and α2, only 10% of the total NKA is α1
(He et al., 2001). Although the α2 isoform is necessary for normal muscle ion transport during
muscle contraction (DiFranco, Hakimjavadi, Lingrel, & Heiny, 2015; Manoharan et al., 2015;
Radzyukevich et al., 2013), it seems unlikely that this small amount of α1 performs a vital ion
transport function that cannot be fulfilled by α2.
The β and γ subunits also display tissue-specific isoform distributions (G. Crambert et al.,
2000; Orlowski & Lingrel, 1988b). The effects of different β isoforms on the enzyme kinetics of
the catalytic α subunit could explain the distribution of the β isoforms in different tissues.
Specifically, the expression of different β isoforms alters the Na+ and K+ affinities of the
associated α isoform (see Table 1). Similarly, γ isoforms exhibit distinct regulation by protein
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kinases (G. Crambert et al., 2000), suggesting that the tissue-specific distribution of the γ
isoforms could facilitate the tissue-specific regulation of NKA activity.
Na/K-ATPase and Skeletal Muscle Ion Homeostasis
Skeletal muscle is an excitable tissue comprised of a heterogeneous mixture of myofibers
with different contractile and metabolic properties (Goodyear, Hirshman, Smith, & Horton,
1991; Gunning & Hardeman, 1991; Stuart et al., 2013; Templeton, Sweeney, Timson, Padalino,
& Dudenhoeffer, 1988), from the oxidative type 1 fibers to mixed type 2a fibers and glycolytic
type 2B/X fibers. Skeletal muscle contains only the ubiquitous α1 isoform and the α2 isoform
(Blanco, 2005a; Cougnon et al., 2002; Fowles, Green, & Ouyang, 2004; He et al., 2001; O'Brien,
Lingrel, & Wallick, 1994; Thompson & McDonough, 1996; Young & Lingrel, 1987). In rodents,
the α1 isoform is primarily found in oxidative slow-twitch fibers, while the α2 isoform is most
dominant in glycolytic slow-twitch fibers, with the α1 isoform primarily found on the
sarcolemma and the α2 isoform localized to the T-tubules and neuromuscular junction (Murphy,
Petersen, et al., 2006; Thompson & McDonough, 1996; L. Zhang, Morris, & Ng, 2006).
However, in humans, there are conflicting reports, with Thomassen et al. reporting significantly
increased α2 expression in glycolytic type 2 fibers (Thomassen, Murphy, & Bangsbo, 2013)
while Wyckelsma et al. reported no difference in fiber type distribution between the α1 and α2
isoforms (Wyckelsma et al., 2015). This discrepancy, however, appears to be at least in part due
to larger variability in the Wyckelsma study. Importantly, neither study reported significantly
lower expression of the α1 isoform in type 2 fibers as has been seen in rodents (Murphy,
Petersen, et al., 2006; Thompson & McDonough, 1996; L. Zhang et al., 2006), although in the
Thomassen study, there appears to be a statistically insignificant decrease in α1 expression in
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type 2 fibers and this, combined with the significantly higher expression of α2 in type 2 fibers,
suggests a decreased α1/α2 ratio in human type 2 fibers as compared to type 1 fibers.
In addition to their fiber type-specific distribution, the NKA α1 and α2 isoforms have
distinct roles in the maintenance of skeletal muscle membrane potentials. The α1 isoform
comprises only 10-15% of the total NKA content in skeletal muscle, with the α2 isoform making
up the other 85-90% (He et al., 2001). The α2 isoform is localized to the neuromuscular junction
and T-tubules, while the α1 isoform is localized to the sarcolemma (Cougnon et al., 2002;
DiFranco et al., 2015; Heiny et al., 2010; Williams et al., 2001).

Figure 2: Schematic diagram of α and β subunits of NKA
Line structure of α and β subunits of NKA, with regions important for signaling highlighted in
purple (caveolin binding motif), yellow (FXYD binding regions), green (Y260 Src binding
region) and blue (NaKtide Src binding region). Additionally, the positions of amino acids
conferring ouabain sensitivity are denoted by red circles, and the residue at which NKA is
phosphorylated during ion pumping is denoted by an orange star. The sequences of the Y260 and
NaKtide regions in different isoforms from various species can be found in Table 3.
This subcellular distribution, along with the decreased K+ affinity of the α2 isoform
compared to the α1 isoform (Table 1), leads to distinct roles for the two isoforms in maintaining
the skeletal muscle membrane potential. The α1 isoform has been identified as responsible for
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maintaining the resting membrane potential, while the α2 isoform is responsible for restoring
membrane potential during muscle contraction (He et al., 2001). This role of the dominant α2
isoform has been further explored with the use of a skeletal muscle-specific α2 knockout mouse
model (skα2-/-). In the absence of α2, the α1 isoform is incapable of maintaining membrane
potential during tetanic contractions in spite of significant compensatory upregulation of α1
expression, leading to increased fatigability and dramatically decreased exercise tolerance
(Radzyukevich et al., 2013). This failure to maintain the membrane potential was later attributed
to the higher K+ affinity of the α1 isoform, which left its enzymatic activity saturated at
physiological K+ concentrations, and to the localization of α1 to the sarcolemma instead of the Ttubules, where extracellular K+ diffuses more slowly and NKA activity is necessary to restore
membrane potential after each depolarizing action potential (DiFranco et al., 2015; Manoharan et
al., 2015). In spite of these clear functional defects, the skα2-/- muscles were not reported to be
different in size or morphology from wild type skeletal muscles (DiFranco et al., 2015;
Manoharan et al., 2015; Radzyukevich et al., 2013).
Hypothesized roles for the α1 and α2 isoforms in skeletal muscle
While maintenance of the membrane potential in contracting muscles is important and α2
functions as the ‘turbocharger’ to restore the membrane potential after the initiation of
contraction, which isoform maintains the basal membrane potential is unclear. The basal
membrane potential impacts contractility, with increased basal membrane potential correlating
closely with force generation (Cairns, Hing, Slack, Mills, & Loiselle, 1997; Overgaard, Nielsen,
& Clausen, 1997). Based on contractility studies in skeletal muscles from α1 haplodeficient
mice, He et al. hypothesized that the NKA α1 isoform is responsible for maintaining the basal
membrane potential. However, while global α1 haplodeficiency did lead to decreased twitch
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force of the extensor digitorum longus (EDL) in vitro (He et al., 2001), the membrane potential
was not directly measured. This mouse model is a global knockdown model that has other
abnormal phenotypes, including a cardiac phenotype (Moseley, Cougnon, Grupp, El Schultz, &
Lingrel, 2004; Moseley et al., 2005), so it is possible that the decreased force generation
observed in α1 haplodeficient muscles is a result of another aspect of their phenotype, for
example, a hormonal or behavioral change that could lead to weaker muscles rather than a
decrease in membrane potential.
Src-Dependent Signaling Function
In 1998, the lab of Zijian Xie identified a novel signaling function of the NKA when they
discovered that the treatment of cardiomyocytes with the NKA-specific ligand ouabain induced
cardiomyocyte hypertrophy via a dose-dependent activation of p42 MAPK (Huang, Li, & Xie,
1997; Kometiani et al., 1998). Follow up studies determined that this Src-mediated signaling
function was isoform-specific (Madan et al., 2017; J. Xie et al., 2015), and that reactive oxygen
species (ROS) mediated this hypertrophic pathway (Z. Xie et al., 1999). This signaling cascade
has since been expanded to include transactivation of the epidermal growth factor receptor
(EGFR) (Haas, Askari, & Xie, 2000), the activation of mitogen activated protein kinase (MAPK)
and Akt pathways (Huang et al., 1997), the activation of the inositol triphosphate (IP3) receptor
and generation of Ca2+ oscillations (Yuan et al., 2005), and the generation of mitochondrial
reactive oxygen species (ROS) (Liu et al., 2006; Z. Xie et al., 1999), linking it to both growth
and metabolism. Additionally, a positive feedback loop in which ROS are capable of activating
α1 signaling through Src has been identified (Yan et al., 2013), leading to the hypothesis that
controlling this signaling pathway may allow for control of ROS stress in disease states.
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The identification of the Src binding domains on NKA α1 led to the development of
NaKtide, a peptide that mimics the ability of α1 to bind Src, thus acting as an inhibitor of CTS
and ROS-stimulated activation of Src through NKA α1 (Z. Li et al., 2009). The drug candidate
pNaKtide was derived from NaKtide, with the addition of positively charged cell-penetrating
peptides, generating pNaKtide. This modification allowed the pNaKtide in the extracellular
space to penetrate the membrane and inhibit Src, thus disrupting the NKA α1/Src signaling
complex. In vivo studies with pNaKtide have revealed that inhibiting NKA α1 signaling through
Src can be protective in such diverse conditions as aging (Sodhi et al., 2018), uremic
cardiomyopathy (J. Liu et al., 2016), myocardial ischemia-reperfusion injury (H. Li et al., 2018),
and diet-induced obesity, steatohepatitis, and insulin resistance (Sodhi et al., 2015; Sodhi et al.,
2017; Srikanthan, Shapiro, & Sodhi, 2016). In all of these studies, intraperitoneal administration
of pNaKtide prevented the pathological increase in ROS and ultimately prevented the
development of severe pathologies.
While the in vivo studies with pNaKtide revealed a key role for α1 in regulating
metabolism, the ubiquitous nature of α1 and the systemic administration of pNaKtide make it
impossible to identify the tissue-specific impacts. In a recent study, Pratt et al. used a lentiviral
transfection system to express pNaKtide specifically in adipocytes. This not only protected
adipose tissue from Western diet-induced metabolic dysfunction, but also prevented the
development of non-alcoholic steatohepatitis and neurodegeneration (Pratt et al., 2019). These
results provide the first evidence that manipulation of α1 signaling can impact cross talk between
tissues. However, much remains unclear about the importance of α1 and α1 signaling in other
tissues, and no genetic models exist to date.
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In addition to this role of NKA signaling in regulating metabolism and growth, signaling
by NKA α1 has been recognized as a driver of development and organogenesis. In 2010, Li et al.
identified the ouabain-stimulated generation of Ca2+ oscillations through NKA signaling as
important for the development of rat kidneys (J. Li et al., 2010). This ouabain-mediated
restoration of normal kidney development in malnourished fetal rats was attributed to the
stimulation of the PI3K pathway through the IP3 receptor (Khodus et al., 2011; J. Li et al.,
2010). More recently, studies in our lab have revealed that the caveolin binding motif found in
the first transmembrane segment of the α subunit (Figure 2), which is a critical component of the
NKA α1/Src signaling scaffold (Bai et al., 2016; Cai et al., 2008; Quintas et al., 2010; H. Wang
et al., 2004), plays a vital regulatory role in embryonic development, especially in neurogenesis
(X. Wang et al.). Furthermore, studies with human induced pluripotent stem cells have shown
that the loss of the caveolin binding motif leads to a loss of stemness and impaired differentiation
(X. Wang et al., 2019). This control of differentiation and organogenesis by NKA α1 caveolin
binding motif has been linked to Wnt/β-catenin signaling independent of Src, but it has only
been partially investigated thus far and the involvement of Src in this regulation cannot be ruled
out.
These multiple signaling functions identified in other cell types offer an alternative
explanation for the presence of the minor NKA α1 isoform in skeletal muscle. However, this
signaling function of α1 has only been explored in skeletal muscle in two papers published by
Kotova et al., who explored a role for the signaling function in cultured C2C12 cells (Kotova,
Al-Khalili, et al., 2006; Kotova, Galuska, Essen-Gustavsson, & Chibalin, 2006). The
differentiated myotubes were treated with ouabain, a NKA-specific ligand that stimulates α1
signaling at low concentrations and inhibits ion pumping of all isoforms at high concentrations.
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After ouabain treatment, cells showed increased glycogen synthesis via the Akt- and ERKmediated inactivation of glycogen synthase kinase 3β (GSK-3β) (Kotova, Al-Khalili, et al.,
2006; Kotova, Galuska, et al., 2006). Because GSK-3β is implicated in the regulation of skeletal
muscle differentiation and the progression of skeletal muscle atrophy (Leger et al., 2006; van der
Velden et al., 2007; Verhees et al., 2011; W. Yang, Zhang, Li, Wu, & Zhu, 2007), this suggested
a link between NKA signaling and the regulation of skeletal muscle metabolism and
development. Furthermore, glycogen content correlates with exercise endurance (Overmyer et
al., 2015; Xu, Ren, Lamb, & Murphy, 2018), so this regulation of glycogen content by NKA
signaling could have implications for exercise performance as well. However, these hypothetical
links between NKA signaling and skeletal muscle metabolism and growth have not been tested
in vitro, and the impact of NKA signaling in skeletal muscle in vivo remains unclear.
Regulation of Na/K-ATPase in Skeletal Muscle Physiology
Skeletal Muscle Development and Growth
Myogenesis involves the progression from pluripotent stem cells to myoblasts to
myotubes to myofibers, which is regulated in a time-dependent manner by skeletal musclespecific factors such as MyoD, MRF4, myogenin, and myostatin. As myoblasts differentiate and
fuse into myotubes and myofibers, cell proliferation ceases, and cells develop rudimentary
contractile machinery. In normal developmental conditions, they further mature into myofibers
with all of the ultrastructure of skeletal muscle including T-tubules and highly coordinated and
organized contractile apparatus (Chal & Pourquie, 2017). During myogenesis, myotubes begin to
express the NKA α2 isoform while expression of NKA α1 begins to decrease (Higham,
Melikian, Karin, Ismail-Beigi, & Pressley, 1993; Orlowski & Lingrel, 1988a, 1988b), a process
that corresponds with the development of T-tubules (Cougnon et al., 2002).
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Even after development, skeletal muscle remains highly plastic, with the ability to expand
in size and cell number after reaching maturity in response to exercise or to injury (Frontera &
Ochala, 2015; Le Moal et al., 2017). Myofibers hypertrophy when they expand in size, a process
that may or may not include the mobilization of satellite cells and thus the integration of more
nuclei/fiber (Murach et al., 2018). Many of the regulators of this process also impact the
expression and activity of NKA in isoform-specific ways (see “Hormonal Regulation of Muscle
Growth and Metabolism” and “Regulation by Exercise”).
The opposite process, skeletal muscle atrophy, occurs in response to a variety of stimuli,
including disuse, cancer-induced cachexia, muscular dystrophies, burn-induced cachexia, and
aging-related sarcopenia (Kinugawa, Takada, Matsushima, Okita, & Tsutsui, 2015; Kravtsova,
Matchkov, & Bouzinova, 2015; Matsuyama et al., 2015; Su et al., 2017). While the stimuli are
different, the process of atrophy and the factors which mediate it are similar in all but muscular
dystrophies. The skeletal muscle loses metabolic flexibility, becoming more glycolytic with
fewer mitochondria and a disrupted mitochondrial network that leads to inefficient mitochondrial
oxidation (Egawa et al., 2015; Leger et al., 2006; Su et al., 2017). Mechanistically, during
skeletal muscle atrophy, mTORC is inactivated, leading to decreased AMPK activation and
increased activation of GSK3β (Egawa et al., 2015; Leger et al., 2006; Verhees et al., 2011).
Disuse-induced atrophy in the vastus lateralis of patients suffering from knee injuries was
associated with a 20% decrease in NKA α1 expression and a 63% decrease in NKA α2
expression (Perry et al., 2015), an effect which has been replicated in rats and the functional
implications of which are not fully understood (Kravtsova et al., 2016). However, while these
key pathways have been identified as important, the master regulators of this process remain
unclear.
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Hormonal Regulation of Muscle Growth and Metabolism
Skeletal muscle has a uniquely plastic metabolism that responds to a variety of stimuli to
adjust ATP production to the metabolic demands of the muscle when at rest and active, in both
fed states and starvation periods. As such, skeletal muscle is a primary target of insulin, with
skeletal muscle comprising approximately 30% of insulin-stimulated glucose uptake (Honka et
al., 2018). In the skeletal muscle, insulin stimulates the translocation of glucose transporter type
4 (GLUT4) to the sarcolemma, thus increasing glucose uptake (Camps et al., 1992).
Simultaneously, insulin leads to increased glycogen storage via inhibition of glycogen synthase
kinase 3β (GSK3β) and an increase in glucose utilization (Camps et al., 1992). In addition to
these metabolic impacts of insulin signaling, the insulin-stimulated activation of a kinase
signaling cascade, including PI3K and p42/44 MAPK, leads to increased anabolism, including
the transcription of growth- and survival-associated proteins (Hoppeler, 2016; H. A. James,
O'Neill, & Nair, 2017; Rhoads, Baumgard, El-Kadi, & Zhao, 2016).
Insulin signaling is also a strong stimulator of NKA activity. Insulin acts on NKA by
phosphorylating the NKA α2 isoform, resulting in increased membrane abundance (Chibalin et
al., 2001). This is especially interesting given the dependence of NKA activity on glycolysis that
has been reported by multiple laboratories in multiple tissues (Lynch & Balaban, 1987a, 1987b;
Sepp et al., 2014) and that has been confirmed in skeletal muscle (J. H. James et al., 1996; J. H.
James et al., 1999; Okamoto, Wang, Rounds, Chambers, & Jacobs, 2001). Interestingly,
increased lactate release as a result of insulin stimulation has been linked to increased NKA
activity in humans (Novel-Chate et al., 2001), which is consistent with the association of the
NKA α2 isoform with both insulin-stimulated increases in NKA membrane abundance (AlKhalili et al., 2004; Chibalin et al., 2001).
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In addition to insulin, thyroid hormone (T3) is an important regulator of skeletal muscle
growth and development, as well as a known regulator of NKA abundance. Skeletal muscle is
partially capable of self-regulating T3 activity through expression of iodothyronine deiodinase 2,
which converts the prohormone T4 into the active T3, and iodothyronine deiodinase 3, which
inactivates T3 (Brent, 2012). T3 then acts on nuclear thyroid receptors to initiate a variety of
cellular processes, including myogenesis through activation of MyoD and Mrf4 (Salvatore,
Simonides, Dentice, Zavacki, & Larsen, 2014) and a switch from fast glycolytic fibers to slow
oxidative fibers (Simonides & van Hardeveld, 2008; D. Zhang et al., 2014). Furthermore, T3 has
been found to regulate NKA activity (Harrison & Clausen, 1998), and muscles from hypothyroid
rats have decreased NKA activity.
The β adrenergic system is also involved in skeletal muscle hypertrophy and adaptation
to exercise training, and inhibition of this hormonal axis is implicated in the development of
skeletal muscle atrophy (Hoppeler, 2016). Skeletal muscle expresses both β1 and β2 adrenergic
receptors, which are both G-protein coupled receptors and have largely overlapping signaling.
When epinephrine or norepinephrine binds to its receptor, adenylase cyclase is stimulated,
leading to the generation of cyclic AMP (cAMP) (Glass, 2003). Increased intracellular cAMP
concentrations then lead to the activation of protein kinase A (PKA), which in turn inhibits the
glycogen synthase-mediated generation of glycogen and increases glycogen degradation by
activating glycogen phosphorylase via activation of phosphorylase kinase. Simultaneously,
glycolysis is increased in order to produce ATP quickly (J. H. James et al., 1999; McCarter et al.,
2001), although glucose transport is not impacted by β adrenergic stimulation (Clausen &
Flatman, 1987). In addition to these short-term effects of β adrenergic stimulation, the activation
of p42/44 MAPK via PKA activation of Rap1 and B-Raf can lead to protein transcription and
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anabolic effects, making β adrenergic receptor agonists one of the preferred performanceenhancing drugs (Glass, 2003).
As in the case of insulin, stimulation of the β adrenergic receptors in skeletal muscle
causes increased NKA activity (Clausen & Flatman, 1977, 1987; Kaibara, Akasu, Tokimasa, &
Koketsu, 1985), which has been linked to changes in glutathionylation of specific subunits (Juel,
Hostrup, & Bangsbo, 2015) and is caused specifically by the activation of β2 adrenergic
receptors (Murphy, Bundgaard, & Clausen, 2006). Unlike insulin, where activation of NKA ion
pumping is largely mediated by increasing the quantity of NKA on the sarcolemma (Chibalin et
al., 2001), stimulation of NKA activity by β adrenergic agonists is largely mediated by increased
Na+ affinity (Buchanan, Nielsen, & Clausen, 2002). This ability of β agonists to increase NKA
activity allows for the retention of muscle contractile force at fatigue (Cairns & Dulhunty, 1993;
Clausen, Andersen, & Flatman, 1993; Hostrup et al., 2014; Nielsen & Clausen, 1997), which
under conditions which would elicit a fight-or-flight response could prove beneficial by
preserving muscle function beyond the normal physiological scope. However, β agonistmediated activation of NKA is also associated with hyperlactatemia in sepsis and hemorrhagic
shock (Bundgaard et al., 2003; Levy, Desebbe, Montemont, & Gibot, 2008; McCarter et al.,
2001; McCarter et al., 2002), and in fact blocking the activation of β adrenergic receptors or
inhibiting NKA in skeletal muscle reduces circulating lactate in these conditions (J. H. James et
al., 1996; Levy, Gibot, Franck, Cravoisy, & Bollaert, 2005; McCarter et al., 2001; McCarter et
al., 2002).
Regulation by Exercise
In addition to the hormonal regulation of skeletal muscle metabolism, such physiological
processes as muscle contraction, energy depletion within the muscle as during exercise, and
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depletion of glycogen stores as in endurance exercise all serve to regulate the muscle metabolism
(Baker, McCormick, & Robergs, 2010; Egan & Zierath, 2013). Skeletal muscle contraction
stimulates glucose uptake independent of insulin action, and the depletion of ATP during
repeated muscle contractions activates AMPK signaling, leading to both short-term and longterm changes in muscle metabolism (Egan & Zierath, 2013). In addition to AMPK signaling,
reactive oxygen species are released by increased mitochondrial metabolism and other, nonmitochondrial sources such as NADPH oxidase and xanthine oxidase (Davies, Quintanilha,
Brooks, & Packer, 1982). This leads to changes in muscle metabolism via the activation of
transcription factors including NF-κB, NFAT, and PGC-1α, including an increased antioxidant
response and increased mitochondrial capacity (Merry & Ristow, 2016).
The physiological impacts of exercise on skeletal muscle also include changes in NKA
isoform expression and activity. Training in humans induces increased plasma NKA distribution
and decreased release of K+ into the blood with intense exercise, suggesting that this increased
plasma distribution leads to increased NKA activity (Green, Chin, Ball-Burnett, & Ranney,
1993). However, this study did not address which isoforms were impacted by the exercise
training. Later studies revealed increased mRNA for α1, α2, and α3 in human vastus lateralis
muscles after acute exercise in both trained and untrained individuals, but increased basal
expression of mRNA only in the α3 isoform (Aughey et al., 2007) Furthermore, acute exercise
was shown to decrease the NKA activity measured in skeletal muscle homogenates, which in
acutely exercised rats has been associated with increased glutathionylation of the NKA (Juel et
al., 2015). Acute treadmill exercise was shown to increase the plasma membrane localization of
all NKA isoforms (α1 and α2, as well as β1 and β2) in both oxidative and glycolytic myofibers
isolated from rats immediately post-exercise (Juel et al., 2001). This effect could be mimicked by
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the in vivo stimulation of skeletal muscles but was reversed in all isoforms in oxidative fibers and
α2 only in glycolytic fibers after 30 minutes of recovery.
However, the response of skeletal muscle metabolism to exercise is largely influenced by
the effect of exercise on the acute and chronic endocrine effects of exercise, such as increased β
adrenergic signaling during acute exercise (Pedersen, 2019) and increased long-term insulin
sensitivity in exercise-trained animals (Egan & Zierath, 2013). As discussed above, these
hormonal changes can have a profound impact on skeletal muscle growth and metabolism and
must be included in any attempts to explain exercise-mediated changes in skeletal muscle.
Additionally, exercise increases circulating levels of endogenous cardiotonic steroids (Bauer et
al., 2005) but the relevance of this to physiology is only speculative. It could be involved in the
regulation of skeletal muscle contractility via inhibition of the α2 isoform of NKA
(Radzyukevich et al., 2009), but due to the very low levels of endogenous cardiotonic steroids in
exercising animals, there could be a role of cardiotonic steroid signaling through the NKA α1/Src
pathway that functions even in the absence of significant ion pump inhibition and has been
linked to metabolism in other systems
A New Role for NKA α1 in Skeletal Muscle Physiology
In light of the NKA α1 signaling pathways identified by multiple laboratories (Cui & Xie,
2017), the classical hypothesis for the role of α1 in skeletal muscle as a regulator of basal
membrane potential needs to be revisited. NKA isoform expression is regulated by the same
hormones that regulate skeletal muscle growth and metabolism, and the one signaling pathway
that has been associated with skeletal muscle NKA α1 signaling is the activation of GSK3β
(Kotova, Al-Khalili, et al., 2006; Kotova, Galuska, et al., 2006), which is associated with
increased muscle atrophy (Leger et al., 2006; Verhees et al., 2011) and decreased proliferation
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with increased differentiation (Agley et al., 2017; van der Velden et al., 2007; W. Yang et al.,
2007). Furthermore, the differential regulation of α1 expression in a fiber-type specific manner,
with higher expression in oxidative, slow-twitch type 1 fibers with smaller twitch force
generation and lower expression in glycolytic, fast-twitch type 2 fibers with larger twitch force
generation challenges the hypothesis that the primary role of NKA α1 in skeletal muscle is basal
membrane maintenance, since larger membrane potentials are associated with larger twitch force
generation (Murphy, Bundgaard, et al., 2006; Overgaard et al., 1997; Overgaard, Nielsen,
Flatman, & Clausen, 1999; Thompson & McDonough, 1996; L. Zhang et al., 2006). Taken
together, these studies suggest that the NKA α1 isoform may have a unique, ion pumpingindependent role in skeletal muscle, and may be associated with the regulation of skeletal muscle
processes as diverse as growth, development, and metabolism.
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Abstract
The distribution of Na/K-ATPase α isoforms in skeletal muscle is unique, with α1 as the
minor (15%) isoform and α2 comprising the bulk of the Na/K-ATPase pool. The acute and
isoform-specific role of α2 in muscle performance and resistance to fatigue is well known, but
the isoform-specific role of α1 has not been as thoroughly investigated. In vitro, we reported that
α1 has a role in promoting cell growth that is not supported by α2. To assess whether α1 serves
this isoform-specific trophic role in the skeletal muscle, we used the Na/K-ATPase α1
haploinsufficient (α1+/-) mice. A 30% decrease of Na/K-ATPase α1 protein expression without
change in α2 induced a modest yet significant decrease of 10% weight in the oxidative soleus
muscle. In contrast, the mixed plantaris and glycolytic extensor digitorum longus (EDL) weights
were not significantly affected, likely due to their very low expression level of α1 compared to
the soleus. The soleus mass reduction occurred without change in total Na/K-ATPase activity or
glycogen metabolism. Serum analytes including K+, fat tissue mass, or exercise capacity were
not altered in α1+/- mice. The impact of α1 content on soleus muscle mass is consistent with a
Na/K-ATPase α1-specific role in skeletal muscle growth that cannot be fulfilled by 2. The
preserved running capacity in α1+/- is in sharp contrast with previously reported consequences of
genetic manipulation of α2. Taken together, these results lend further support to the concept of
distinct isoform-specific functions of Na/K-ATPase α1 and α2 in skeletal muscle.
Introduction
The Na/K-ATPase was discovered over 60 years ago as the membrane-bound protein
complex that catalyzes the active transport of K+ into and Na+ out of the cell, thereby
maintaining the resting membrane potential and excitability. The minimal functional Na/KATPase unit is made up of two subunits, α and β. The α-subunit is the catalytic subunit and bears
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the binding sites for ATP, ions and cardiotonic steroids (CTS) (Pierre & Xie, 2006). In addition
to the ubiquitously present α1, three isoforms of the catalytic subunit have been characterized.
Na/K-ATPase α2 is found mainly in muscle, adipose and glial cells, α3 mainly in neurons, and
α4 expression is restricted to sperm (Blanco, 2005a). This highly tissue-specific expression
pattern and isoform-specific response to both physiological and pathological stimuli have long
suggested that they must be serving tissue-specific functions.
Over the last fifteen years, we and others have reported that Na/K-ATPase α1 serves
important scaffolding and signaling functions in addition to its role as an ion pump (Pierre &
Xie, 2006). Specifically, α1 can interact with and modulate Src activity, which in turn affects
EGF receptors through transactivation. This subsequently adjusts the assembly and activation
levels of multiple protein/lipid kinases as well as the generation of reactive oxygen species
(ROS) and other intracellular messengers, allowing endogenous CTS to regulate cell growth
(e.g., kidney development) (Fontana et al., 2013; Kometiani et al., 1998; Yan et al., 2013). On
the other hand, sustained and dysregulated activation of this signaling mechanism causes ROS
stress and pathological remodeling in the heart and kidneys (Liu et al., 2006; Tian et al., 2009;
Wansapura, Lasko, Lingrel, & Lorenz, 2011).
In the skeletal muscle, the role of the ion-pumping function of the dominant α2 isoform
in maintaining the membrane potential during contraction has been studied extensively
(DiFranco et al., 2015; He et al., 2001; Heiny et al., 2010; Manoharan et al., 2015; Radzyukevich
et al., 2009; Radzyukevich et al., 2013). Additionally, Radzyukevich et al. have described an
improvement in exercise performance in mice expressing a ouabain-resistant mutant α2 isoform,
suggesting a role of endogenous CTS in the regulation of muscle contraction via the α2 isoform
(Radzyukevich et al., 2009). Interestingly, expression of ouabain-resistant α2 or even α2

22

knockout did not affect skeletal muscle mass (DiFranco et al., 2015; Heiny et al., 2010;
Manoharan et al., 2015; Radzyukevich et al., 2009; Radzyukevich et al., 2013). In a renal
epithelial cell knockdown and rescue system, we have obtained evidence that the α1 isoform is
important for cell growth, and that rescue with α2 restores ion-pumping capacity but does not
restore growth or Src-dependent signal transduction in response to ouabain binding at
concentrations too low to impair enzymatic activity (J. Xie et al., 2015). Taken together, the
apparent lack of impact of α2 in skeletal muscle mass in genetic mouse models and the inability
to support cell growth in the absence of α1 in vitro are consistent with a model whereby α1, but
not α2, plays a role in the regulation of skeletal muscle mass. To test this model, we investigated
the impact of α1 reduction on muscle mass in Na/K-ATPase α1 haplodeficient mice (α1+/-) and
control littermates (α1+/+). This mouse model has been previously used to examine α1 and α2isoform specific functions in the heart (P. F. James et al., 1999; Moseley et al., 2004; Moseley et
al., 2005) and the skeletal muscle (He et al., 2001). While the latter study specifically focused on
the glycolytic Extensor Digitorum Longus (EDL) muscle and the respective roles of α1 and α2 in
the maintenance of ion homeostasis during contraction, we extended our search for a trophic role
of α1 to the three muscle types (oxidative, mixed and glycolytic).
Materials and Methods
Reagents.
The polyclonal anti-Na/K-ATPase α1 antiserum NASE and polyclonal anti-Na/KATPase α2 antiserum HERED used for Western blots were raised in rabbits and were generous
gifts from Drs. T. Pressley and P. Artigas at Texas Tech University Health Sciences Center
(Pressley, 1992). Antibodies for phospho-serine 9 glycogen synthase kinase 3β and total
glycogen synthase kinase 3β were from Cell Signaling (catalog number 9322S and 9315S,
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respectively). Anti-α tubulin antibody (Sigma, catalog number T5168) or anti-β actin antibody
(Santa Cruz, catalog number sc-7210) were used as a loading control. Secondary antibodies were
horseradish peroxidase-conjugated anti-rabbit and anti-mouse from Santa Cruz Biotechnology
Inc (catalog number sc-2004 and sc-2005, respectively).
Animals.
Mice heterozygous for the Na/K-ATPase α1 isoform were developed by Dr. J Lingrel’s
group at the University of Cincinnati (P. F. James et al., 1999). The colony was backcrossed to
C57J/Bl6 mice from Jackson Labs and maintained through a heterozygous x wild type breeding
scheme, resulting in α1+/- experimental animals and littermate controls. Male α1+/- mice and
control littermates were housed in 12-hour light and dark cycles at constant temperature and
humidity until 6 months of age. All animal procedures were approved by the Marshall University
Institutional Animal Care and Use Committee.
Treadmill testing.
Six-month-old male α1+/- mice and litter mate controls were placed in the six lanes of an
Exer 3/6 treadmill from Columbus Instruments equipped with a shock detection system. Animals
were acclimated to the treadmill for 3 days at 5 m/min for 5 minutes at a 5° angle and were
subjected to the testing protocol on the fourth day. Mice began the testing protocol running at 5
m/min for five minutes and increased by 2 m/min each minute up to 25 m/min, then continued
running at 25 m/min until they reached fatigue. Each shock administered and each visit to the
shock grid was recorded for each animal. Fatigue was defined as 10 consecutive seconds spent
on the shock grid, and the shock was discontinued to each mouse upon reaching fatigue.
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Tissue collection.
Mice were anesthetized with 50 mg/kg pentobarbital administered via IP injection.
Tissues were dissected and weighed. Muscles used for Western blot analysis or enzymatic
activity assays were flash frozen in liquid nitrogen then stored at -80° C until later use. Muscles
used for histological analysis were fixed in 10% neutrally buffered formalin for 24 hours then
stored in 70% ethanol until they were embedded in paraffin blocks.
Western blot.
Left and right muscles of the same type from the same mouse were homogenized
together in ice-cold radioimmunoprecipitation (RIPA) buffer (0.25% sodium deoxycholate, 1%
Nonidet P-40, 1mM EDTA, 1mM PMSF, 1mM sodium orthovanadate, 1mM Sodium fluoride,
150 mM NaCl, 50 mM Tris-HCl, pH 7.4 and 1% protease inhibitor cocktail) with a Fisher
TissueMeiser homogenizer. Homogenates were centrifuged at 14,000 X g for 15 min,
supernatants were collected, and the protein content was measured using DC Protein Assay Kit
from BioRad (catalog number 500-0114 and 500-0113). Equal amounts of protein of each
sample were loaded, separated by SDS-PAGE, and transferred to nitrocellulose membranes.
Membranes probed for α1 and α2 were blocked in 5% milk, then primary antibodies were added
overnight at 4°C. Membranes were visualized with Western Lightning® Plus-ECL (Western
Lightning) and radiographic film. Densitometric quantification was performed using ImageJ
software from the National Institute of Health.
Membrane fractionation.
Crude membrane fractions were prepared from frozen α1+/- and α1+/+ gastrocnemius
muscles following a procedure modified from Walas and Juel (Walas & Juel, 2012). Frozen
muscles were ground into a fine powder with a mortar and pestle. The resulting powder was
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homogenized in ice-cold fractionation buffer (250 mM mannitol, 30 mM L-histidine, 5 mM
EGTA and 0.1% deoxycholate, adjusted to pH 6.8 with Tris-base) for 30 seconds with a Fisher
Tissue Meiser handheld homogenizer. The crude homogenate was centrifuged at 3000xg for 30
minutes and the supernatant was then centrifuged at 190,000xg for 90 minutes. The pellet was
resuspended in 30 mM histidine, 250 mM sucrose, and 1 mM EDTA, pH 7.4, and protein
concentration was determined using the DC Protein Assay Kit from BioRad (catalog number
500-0114 and 500-0113).
ATPase activity assay.
Ouabain-sensitive ATPase activity in crude membrane fractions was determined by
measuring ATP hydrolysis as previously described (Belliard et al., 2016; Belliard, Sottejeau,
Duan, Karabin, & Pierre, 2013). Released inorganic phosphate (Pi) was detected using a
malachite-based Biomol Green reagent. Samples containing 10 µg of protein were added to a
reaction mix containing 20 mM Tris-HCL, 1 mM MgCl2, 100 mM NaCl, 20 mM KCl, and 1
mM EGTA-Tris, pH 7.2. Ouabain was added to the samples to a final concentration of 1 mM to
completely inhibit both α1 and α2 isoforms of the Na/K-ATPase. After 10 minutes of
preincubation at room temperature, the reaction was started by adding Mg-ATP at a final
concentration of 2.25 mM and incubation at 37°C with shaking for 30 minutes. The reaction was
stopped with the addition of ice-cold 8% TCA, and the concentration of Pi was measured
spectrophotometrically at OD 620 nm using Biomol Green as an indicator (Enzo Life Sciences
catalog # BML-AK111-250). Maximal Na/K-ATPase activity was calculated as the difference
between ATPase activity obtained in the absence or presence of 1 mM ouabain.
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Immunohistochemistry.
Muscles were collected and then washed twice with ice-cold PBS, fixed with 10%
neutrally buffered formalin for 24 hours, and embedded in paraffin. Transverse sections of the
midbelly were immunostained for myosin heavy chain (Myhc) fast and Myhc slow by Wax-It,
Inc., as described by Behan et al. (Behan, Cossar, Madden, & McKay, 2002) to differentiate
between type 1 and type 2 fibers. Additional sections were stained for Na/K-ATPase α1 by WaxIt, Inc. (Vancouver, Canada). The samples were examined on a Leica confocal SP5 microscope
(Leica Microsystems,Wetzlar, Germany). The images were processed with the Leica Application
Suite Advanced Fluorescence (LAS/AF) suite (Leica Microsystems, Wetzlar, Germany), FIJI
platform, and the GNU Image Manipulation Program (GIMP) to obtain maximum projections,
extract lateral slices, and construct figures.
Morphometric tissue analysis (CSA and fiber types).
Images of muscles stained for fast and slow myosin heavy chain were obtained by WaxIt, Inc. with digital whole-slide scanning. Aperio ImageScope software was used to determine the
cross sectional area (CSA) of each fiber. Fibers that had been damaged were excluded from CSA
analysis. Every fiber of each type in each muscle was counted to determine the average number
of fibers per muscle.
Glycogen content analysis.
Glycogen was assayed in whole-muscle homogenates using a colorimetric glycogen
assay kit from Abcam (catalog number ab169558) according to manufacturer’s instructions.
Serum analytes.
Whole blood was collected from the hepatic portal vein then allowed to clot for 15
minutes in 0.8 mL SST-MINI tubes with clot activator and gel. The blood was then centrifuged
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at 2000 rpm for 15 minutes. Clear serum was transferred to 1.5 mL transport tubes and analyzed
by IDEXX Bioresearch using a Beckman AU680 Chemistry System.
Data Analysis.
Data presented are mean ± S.E.M, and statistical analysis was performed using the
Student’s t test. When more than two groups were compared, one-way ANOVA was performed
prior to post-hoc comparison of individual groups using Dunnet’s multiple comparison test.
Significance was accepted at P < 0.05.
Results
Skeletal muscle Na/K-ATPase in α1 haplodeficient mice
He et al. first reported a significant decrease in Na/K-ATPase α1 expression in α1+/muscle, but their study focused on one of the three main types of muscle, the glycolytic Extensor
Digitorum Longus (EDL) (He et al., 2001). In the present study, the extent of Na/K-ATPase α1
expression decrease was assessed in all muscle types. Specifically, western blot analyses were
performed in a representative oxidative (soleus), a mixed (plantaris) and a glycolytic (EDL)
muscle. As shown in Figure 3A, α1 expression in α1+/- mice was decreased by 30-40% in all
muscle examined (p<0.05 vs α1+/+). Further, no compensatory increase in α2 expression was
observed (Figure 3A), and the expression of the regulatory FXYD1 subunit was also unchanged
(data not shown). The decrease of Na/K-ATPase α1 was also clear after immunofluorescence
labeling using a α1-specific antibody in histological preparations of soleus and EDL muscles (1B
and C). To assess the impact of this reduction of α1 on total Na/K-ATPase activity, a preparation
of the gastrocnemius, a mixed muscle of larger size, was used. A decrease of α1 without
detectable change in α2 expression comparable to that of the three other muscles tested was
observed by Western blot (2A). As shown in Figure 4B, maximal Na/K-ATPase activity was not
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different between α1+/+ and α1+/- crude membrane fractions (ouabain-inhibited ATPase activity
of 1.91 ± 0.23 μmol/µg protein/hr in α1+/+ membrane fractions compared to 2.01 ± 0.40
μmol/µg protein/hr in α1+/- membrane fractions).

Figure 3. Na/K-ATPase α-isoform abundance in skeletal muscles from Na/K-ATPase α1
haplodeficient mice (α1+/-) and control littermates (α1+/+).
A. Representative Western blots for Na/K-ATPase α1 and α2 isoforms in soleus (oxidative),
plantaris (mixed), and EDL (glycolytic) muscle homogenates are shown with n=2/genotype. The
quantitative data are means ± S.E.M. from 7-9 specimens/group normalized to the average of the
α1+/+ controls on each gel. B and C. Representative immunohistochemical staining for Na/KATPase α1 isoform in soleus (B) and EDL (C) from α1+/+ and α1+/- mice.
Na/K-ATPase α1 reduction affects oxidative but not mixed or glycolytic muscle size.
Based on the recent finding that removing α1 causes decreased growth in an in vitro
system (J. Xie et al., 2015), we investigated the impact of reduced α1 expression on skeletal
muscle size in α1+/- mice compared to α1+/+. Mice were age-matched at 6 months and exhibited
no differences in body weight. Consistent with previous studies (P. F. James et al., 1999), there
were no major abnormalities detected in basal conditions and kidney weight/body weight ratio
and heart weight/body weight ratios were comparable (Table 2). Consistent with previous
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observations in these animals (He et al., 2001), the mass to body weight ratio of the glycolytic
EDL did not change in α1+/- mice (Figure 5). Likewise, the mass of the mixed-type plantaris
was comparable (Figure 5). In contrast, the mass-to-body weight ratio of the oxidative soleus
muscle was decreased by 9%, from 0.230 ± 0.009 mg/g for α1+/+ mice to 0.209 ± 0.006 mg/g
for α1+/- mice (P<0.05).

Table 2: Selected physiological parameters in Na/K-ATPase α1 +/+ vs α1 +/- mice.
Data are presented as means ± SEM. For body weight, age, and tibia length, n=30-40. For heart
and kidney weight/body weight (BW), n=20-33. Adipose weight represents the combined
weights of the epidydimal and inguinal fat pads (n=7-8). Serum concentrations of K+, Na+, and
glucose were measured in blood collected from the hepatic portal vein of fed mice (n=4). No
significant difference was observed.
Expression of Na/K-ATPase α1 in skeletal muscle types.
Previous studies of Na/K-ATPase isoforms have described a muscle-type specific
distribution of α1 and α2 in rats, with the oxidative soleus containing more α1 than any other
muscle type studied and the glycolytic EDL expressing the least (Thompson & McDonough,
1996). Hence, higher expression level could explain the relative high impact of α1 depletion in
the soleus compared to other muscle types in the mouse. This was evaluated by western blot in
the oxidative soleus and red gastrocnemius, the glycolytic EDL and white gastrocnemius, and
mixed plantaris muscles of C57Bl6 mice. As shown in Figure 6, expression of α1 decreases as
muscles become increasingly glycolytic, with the oxidative soleus expressing significantly more
α1 than either the mixed plantaris or the glycolytic EDL. The sharp contrast between α1
expression in the soleus vs. EDL was confirmed by immunofluorescence (4C), and is consistent
with a relative lack of detectable impact on growth upon reduction by 30%. A difference in α2
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expression between muscle types was also detected, although not as pronounced and less
systematically correlated with muscle type.

Figure 4. Na/K-ATPase activity.
A. Representative Western blots for Na/K-ATPase α1 and α2 isoforms in gastrocnemius muscle
homogenates are shown with n=2/genotype, and the quantitative data are means ± S.E.M. from 4
specimens/group normalized to the average of the α1+/+ controls on each gel. B. Maximal
ATPase activity in crude membrane fractions from α1+/+ and α1+/- gastrocnemius muscles.
ATPase activity was measured by Pi release with a colorimetric indicator. (n=6-7)
Decreased cross-sectional area without change in muscle fiber number in the soleus
To determine which structural changes were associated with the decreased muscle mass
in the soleus, we examined the number and size of myofibers in α1+/- vs. α1+/+ soleus muscles
after staining for fast and slow myosin heavy chain from 4 muscles per group. As shown in
Figure 7A, fiber composition of the α1+/- soleus was not different from α1+/+. However, fiber
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cross sectional area was significantly decreased by 10% in α1+/- soleus muscles, suggesting that
the decrease in muscle mass was due to changes in fiber size rather than number. This change in
fiber size was observed in both type 1 and type 2a fibers of the soleus (Figure 7A). In contrast,
the EDL exhibited no change in either fiber number or fiber cross sectional area, which is
consistent with the lack of impact on overall muscle size (Figure 7B).
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Figure 5. Changes in muscle mass in α1+/- mice.
Muscle mass of soleus, plantaris, and EDL in α1+/+ and α1+/- mice. The quantitative data are
means ± S.E.M. from 23 α1+/+ or 40 α1+/- mice. *p<0.05.
Glycogen content and GSK3β status in the soleus
Na/K-ATPase α1 signaling pathway is a modulator of glycogen synthesis and glycogen
synthase kinase 3β (GSK3β) in skeletal muscle cells (Kotova, Al-Khalili, et al., 2006) and may
therefore lead to a change in size, growth and differentiation in the soleus of α1+/- mice (Agley
et al., 2017; Leger et al., 2006; van der Velden et al., 2007; Verhees et al., 2011). Accordingly,
we compared glycogen content and GSK3β in α1+/- and α1+/+ soleus muscles. As shown in
Figure 8A, Western blot analysis did not reveal any difference in GSK3β content or serine 9
phosphorylation between α1+/+ and α1+/- muscles from fed mice. Consistent with this result,
glycogen content was comparable in α1+/+ and α1+/- soleus muscles (Figure 8B).
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Figure 6. Na/K-ATPase α-isoform abundance in skeletal muscles from C57Bl6 mice.
A. Representative Western blots for Na/K-ATPase α1 and α2 isoforms in oxidative (soleus and
red gastrocnemius (R Gastroc)), mixed (plantaris), and glycolytic (EDL and white gastrocnemius
(W Gastroc)) muscles are shown with n=2/muscle type. B. Quantitative data are means ± S.E.M.
from 6 specimens/group normalized to the average of the soleus on each gel. * p<0.05 and
***p<0.0001 vs soleus. C. Representative micrographs of immunohistological staining for Na/KATPase α1 in soleus (left) and EDL (right), with quantification of 3 samples/group. **p<0.001.
Exercise performance
As shown in Table 2, the 10% change in muscle mass observed in some but not all
muscles of the α1+/- mouse was not accompanied by a noticeable change in physiological
parameters related to growth (tibia length) or metabolic dysregulation (glycaemia, adipose tissue
mass), or K+ homeostasis in basal conditions. To test whether the observed structural changes in
α1+/- soleus size affected exercise performance in 6-month-old mice, two treadmill exercise
paradigms were used. A gradual increase in velocity allowed us to assess changes in tolerance to
high speeds and high intensity exercise, and a prolonged time at 25 meters per minute allowed us
to determine whether endurance exercise was affected. As shown in Figure 9, the number of
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shocks at each speed remained unchanged, suggesting that the reduced amount of α1 present in
the α1+/- muscle did not prevent animals from running at high speeds. Furthermore, the distance
to fatigue was unchanged.

Figure 7. Structural changes in the soleus muscle of Na/K-ATPase α1 haplodeficient mice.
Soleus and EDL muscles were dissected and weighed, then cross sections of the midbelly of
paraffin-embedded soleus muscles were stained for fast and slow myosin heavy chain (Myhc).
Cross sectional areas (CSA) of the fibers were determined using Aperio ImageScope software.
A. Representative micrographs of α1+/+ and α1+/- soleus muscles, with type I and type II fibers
shown with white and black arrows respectively. Quantifications of cross sectional areas of type
I and type II fibers from 4 soleus muscle/group and total number of fibers of each type in each
soleus muscle (n=4). ** p<0.005 and ***p<0.0001 vs cross sectional area in α1+/+ littermates.
B. Representative micrographs of α1+/+ and α1+/- soleus muscles. Quantifications of cross
sectional areas of type II and total number of fibers of each type in each EDL muscle (n=4-5).
No significant difference was observed.
Discussion
Based on our observations in renal epithelial cell lines, Na/K-ATPase α1 possesses
isoform-specific functions that are not supported by α2, which results in a sizable effect on cell
growth rate (J. Xie et al., 2015). Since renal epithelial cells do not normally express Na/KATPase α2, we took the next step of investigating this issue in a tissue expressing both isoforms.
We focused on the skeletal muscle, a tissue where α2 expression uniquely predominates over the
minor α1 isoform and with a regenerative process that occurs throughout life. Specifically, we
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used the Na/K-ATPase α1+/- mouse model to investigate whether a downregulation of the minor
pool of Na/K-ATPase α1 expressed in skeletal muscle could affect muscle mass. The data
indicate that a 30-40% decrease of Na/K-ATPase α1 protein expression, which does not
noticeably decrease total maximum Na/K-ATPase capacity of the muscle, induces a modest yet
significant decrease of 10% in the mass of the oxidative soleus (Figure 5). In contrast, the mass
of the glycolytic EDL was not affected, nor was that of the mixed-type muscle plantaris (Figure
5). The very low level of α1 expression in the EDL and the plantaris compared to the soleus may
explain this intriguing muscle-type specific effect. Indeed, as shown in Figure 6 and consistent
with previous studies in rats by Thompson and McDonough (Thompson & McDonough, 1996)
and others (Chaillou et al., 2011; Fowles et al., 2004), the oxidative soleus expresses
substantially more α1 than the glycolytic EDL in wild-type mice. Moreover, when the western
blot analysis was extended to additional representative muscles of each type, a positive
correlation between α1 content and oxidative metabolism was observed, suggesting that the role
of α1 could be particularly important in oxidative fibers. Mechanistically, we speculate that
endogenous cardiotonic steroid (CTS) signaling through α1 may have a role in maintaining the
growth of the soleus, and the lack of this ouabain signaling could be responsible for the reduced
soleus mass in α1+/- mice (Figure 5). It should be noted that the mouse α1 isoform has a much
lower affinity for ouabain than α2, and only 0.05% of the α1 isoform is bound to ouabain at the
reported endogenous ouabain concentrations (Bauer et al., 2005; O'Brien et al., 1994). However,
through amplification of signaling cascades, concentrations of ouabain comparable to circulating
endogenous ouabain can activate signaling in cells and tissue expressing such low affinity α1
(Aydemir-Koksoy, Abramowitz, & Allen, 2001; Dvela-Levitt et al., 2015; Dvela, Rosen, BenAmi, & Lichtstein, 2012; Fontana et al., 2013). In contrast, pumping inhibition is directly related
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to the number of pumps bound to ouabain, which means that signaling could have a long-lasting
impact at concentrations too low to affect the membrane potential or ion homeostasis. Although
this remains to be specifically tested, a plausible model is that the higher expression level of α1
in the soleus enables endogenous CTS-stimulated signaling, as seen in other cell lines and tissue
types (Aydemir-Koksoy et al., 2001; Cui & Xie, 2017; Fontana et al., 2013; Kometiani et al.,
1998; Tian et al., 2009). Consistent with our observation that a 50% reduction in α1 expression
prevents ouabain from stimulating signaling and growth in renal epithelial cells (Tian et al.,
2009), α1 expression in the EDL (6% of soleus) or plantaris (23% of soleus) may not allow CTSstimulated growth through stimulation of Na/K-ATPase α1 signaling. Although signaling of the
CTS ouabain through Na/K-ATPase α1 modulates glycogen synthesis through GSK3β signaling
in skeletal muscle cells (Benziane et al., 2012) and may therefore lead to a change in size, growth
and differentiation in the soleus of α1+/- mice (Agley et al., 2017; Leger et al., 2006; van der
Velden et al., 2007; Verhees et al., 2011), we did not detect a significant change in the 6 month
old mouse (Figure 8). This result certainly warrants further investigation, as a dysregulation of
GSK3β may have occurred at an earlier time point and/or may only be discernible under agonist
stimulation.
Skeletal-muscle specific ablation of Na/K-ATPase α2 does not affect muscle mass
(DiFranco et al., 2015; Manoharan et al., 2015; Radzyukevich et al., 2013), which suggests that
the observed decrease in soleus mass in the α1+/- is likely unrelated to altered ion-pumping
capacity of the cell. Consistently, we did not detect any significant decrease in Na/K-ATPase
activity in crude membrane preparations from α1+/- muscles. Based on an α1 contribution of
about 15% of total skeletal muscle Na/K-ATPase (He et al., 2001) and a decrease of about 40%
of α1 in the α1+/- skeletal muscle, the expected decrease in Na/K-ATPase activity would have
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been minimal (about 6%), and may have remained below the limit of detection of the assay
(Heiny et al., 2010; Ingwersen et al., 2011; Walas & Juel, 2012). On the other hand, it is well
established that most cells have a large reserve pump capacity and that a decrease in the number
of Na/K-ATPase expressed at the cell membrane can be compensated by either a substratemediated stimulation of existing pumps or a mobilization of the reserve pump pool (T. Akera &
Brody, 1982; Tai Akera & Brody, 1985). Finally, although we consider it unlikely because a
decreased myofiber diameter as observed in α1+/- muscles is not expected as a secondary
adjustment for optimization of ion pumping capacity and maintenance of the membrane potential
(in fact, fibers with larger rather than smaller diameters require significantly less energy to
maintain their membrane potential (Jimenez, Dasika, Locke, & Kinsey, 2011; Jimenez,
Dillaman, & Kinsey, 2013)), it should be noted that a change in Na/K-ATPase ion-transport
activity secondary to α1 depletion has not been specifically excluded in this study.

Figure 8. A. GSK3β and glycogen content in the soleus muscle of Na/K-ATPase α1
haplodeficient mice.
Representative Western blots for phospho serine 9 glycogen synthase kinase 3β (p-Ser9 GSK3β)
and total glycogen synthase kinase 3β (GSK3β) in α1+/+ and α1+/- soleus muscles. Quantitative
data are means ± S.E.M. from 4 specimens/group. Phospho-Ser9 GSK3β /total GSK3β ratios
were normalized to the average of the α1+/+ controls on each gel. B. Glycogen content of soleus
muscles presented as means ± S.E.M. from 6-7 samples per group.
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This model of a change in muscle mass related to α1-specific signaling function is also
consistent with the concept of distinct and specific roles for α1 and α2 in skeletal muscle initially
suggested by He et al. Indeed, the authors first proposed that α1 is primarily responsible for
establishing a baseline membrane potential, and α2 maintains the membrane potential during
contraction (He et al., 2001). This role for α2 was subsequently confirmed by a series of studies
using skeletal muscle specific ablation of α2 in mice. In those studies, muscle mass of both EDL
and soleus was unchanged, but maintenance of the membrane potential during contraction was
severely impaired due to an inability to clear the excitation-dependent increase in extracellular
[K+]o (DiFranco et al., 2015; Manoharan et al., 2015; Radzyukevich et al., 2013). Taken together,
those studies and the results presented here support a model where skeletal muscle α2 has an
isoform-specific role in the maintenance of membrane potential during contraction related to its
enzymatic activity, whereas α1 has, in addition to its transport function, an isoform-specific role
in growth that is independent of its ion-pumping activity.

Figure 9. Distance to fatigue in Na/K-ATPase α1 haplodeficient mice (α1+/-) and control
littermates (α1+/+) during forced treadmill running.
A. Number of shocks administered per animal per minute at increasing speeds during testing of
6-month-old mice (n=7-9/group; α1+/+ black circles; α1+/- grey squares). B. Distance to fatigue
for 6-month-old α1+/+ and α1+/- animals (n=7-9).
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While the effect of α1 haplodeficiency on muscle growth may seem modest at first, it is
important to note that it is relevant to reported models of skeletal muscle atrophy. The soleusspecific decrease in muscle mass, accompanied by a reduction of fiber size but not fiber number,
is a feature of disuse-induced atrophy induced by hind limb suspension (Egawa et al., 2015;
Kravtsova et al., 2016). Although this decrease in size is relatively minor compared to some
forms of atrophy, it is comparable to the 10-15% decrease in gastrocnemius mass in burn
cachexia reported by Pedroso et al. (Pedroso et al., 2012). Similarly, the commonly used
subcutaneous inoculation model of cancer cachexia consistently decreases muscle mass by 615% (Choi et al., 2013; Matsuyama et al., 2015; Murphy et al., 2011; X. Wang, Pickrell,
Zimmers, & Moraes, 2012). As may have been expected with a relatively modest decrease, the
α1+/- mouse model does not present with major metabolic abnormalities in basal conditions
(Table 2). Perhaps more surprising is the lack of defects in exercise capacity (Figure 9), given
that He et al. found that the tetanic force of isolated α1+/- EDL muscles is decreased in vitro (He
et al., 2001). This apparent discrepancy is likely due to the global haplodeficiency of the α1+/mouse model, which affects other systems involved in exercise, including the nervous,
cardiovascular, and endocrine systems.
Clearly, inherent limitations due to global and incomplete reduction of Na/K-ATPase α1
in the α1+/- model warrant future studies in a skeletal muscle-specific model. While such model
seems required to fully assess the scope and significance of the proposed new isoform-specific
trophic role for Na/K-ATPase α1 in the skeletal muscle, several important conclusions can be
drawn from the present study. First, the α1-specific trophic role observed in vitro is relevant in
vivo. Second, manipulation of Na/K-ATPase α1 content leads to morphological changes in the
skeletal muscle that do not impact maximal running capacity, in contrast to manipulation of α2
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which did not affect muscle size but affected running capacity. These lend further support for the
concept that Na/K-ATPase α1 and α2 serve distinct and isoform-specific functions in the skeletal
muscle. Finally, the findings presented here suggest a novel mechanism for exercise-induced
changes in muscle size and metabolism. Physiologically, exercise increases serum concentrations
of endogenous Na/K-ATPase ligands such as ouabain and leads to modifications of skeletal
muscle structure and function (Bauer et al., 2005; Egan & Zierath, 2013). Alteration of muscle
activity during exercise through modulation of α2 by endogenous Na/K-ATPase ligands has been
demonstrated (Radzyukevich et al., 2009), and the present study now suggests that they may also
modulate changes in oxidative skeletal muscle structure in response to exercise training through
the modulation of α1 signaling. These new findings suggest a possible impact of endogenous or
pharmacological administration of CTS on muscle growth, which could be further investigated
using the established mouse line expressing ouabain-sensitive α1 (Dostanic-Larson et al., 2006).
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Summary
Mammals have acquired increased metabolic capacity to support growth and endurance.
Paradoxically, they also become insulin resistant when fed with Western diet. We find that the
acquisition of Src binding sites in the α1 Na/K-ATPase (NKA) occurred during endothermy
evolution. The loss of Src binding diminishes metabolic capacity in cell culture, which is
confirmed by phenotypic changes observed in a skeletal muscle-specific α1 knockout (skα1-/-)
mouse model. However, skα1-/- mice are resistant to diet-induced insulin resistance. Similar
protection is observed in wild type mice treated with pNaKtide, an inhibitor of α1 NKA/Src
complex. These results suggest that the acquisition of Src binding by α1 NKA is responsible for
the dichotomy of increased metabolic capacity at the cost of decreased tolerance for Western
diet. Therefore, we suggest that the α1 NKA/Src complex may underlie the molecular basis of
endothermy evolution and serve as a new target for metabolic syndrome therapeutics.
Introduction
Metabolic capacity, comprised of reserve and flexibility, is vital for maintaining
homeostasis when faced with changing energy demands and fuel availability. As endotherms,
mammals have increased metabolic capacity compared to ectothermic animals. The aerobic
scope hypothesis posits that the evolution of endothermy relied on increased metabolic capacity
to facilitate not only endothermy but the increased ambulatory endurance associated with
endothermy (Griffin, Humphries, Kinter, Lim, & Szweda, 2016). However, mammals also
developed intolerance to overnutrition. The development of diet-induced metabolic syndrome in
mammals is associated with the loss of metabolic flexibility and involves the overproduction of
reactive oxygen species (ROS) and the development of chronic inflammation, leading to insulin
resistance, glucose intolerance, hepatic steatosis, and obesity. Furthermore, the loss of metabolic
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capacity is observed in many end-stage chronic human diseases such as heart failure, liver
failure, and steatohepatitis (Galgani, Moro, & Ravussin, 2008; Peterzan, Lygate, Neubauer, &
Rider, 2017; Poussin et al., 2011; Su et al., 2017; Z. V. Wang, Li, & Hill, 2014). Conversely,
increased metabolic capacity is linked to improved health outcomes (Apostolopoulou et al.,
2016; Carson, Hardee, & VanderVeen, 2016; Goodpaster & Sparks, 2017; Koves et al., 2008;
Meex et al., 2010; Overmyer et al., 2015; Peterzan et al., 2017). Despite the importance of
metabolic reserve and flexibility in mammalian pathophysiology, the mechanisms by which they
are regulated are only minimally understood and the mechanism of increased metabolic capacity
in mammals has yet to be identified (Goodpaster & Sparks, 2017).

Figure 10: Evolutionary relationships between vertebrate groups listed in Table 3.
Endotherms are written in red, ectotherms in blue.
In addition to its role as an ion transporter, the ubiquitous mammalian Na/K-ATPase
(NKA) α1 isoform encoded by the ATP1A1 gene has been identified as an important signaling
platform due to its ability to form a functional receptor complex with Src (Cui & Xie, 2017). The
four mammalian isoforms of the α subunit evolved from the invertebrate α subunit and form their
own clade, with mammalian ATP1A1 as the most recently evolved isoform (Kakumura et al.,
2015; Saez, Lozano, & Zaldivar-Riveron, 2009; W.-K. Yang et al., 2019). Among the processes
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regulated by α1 NKA/Src signaling are the Warburg effect, a switch to anaerobic metabolism in
cancer (Banerjee et al., 2018), and increased mitochondrial ROS production, which can further
activate the α1 NKA/Src pathway and generate a positive feedback loop (Yan et al., 2013).
Targeting this signaling through α1 NKA has been shown to attenuate metabolic syndrome
(Sodhi et al., 2015; Sodhi et al., 2018; Sodhi et al., 2017; Srikanthan et al., 2016), and decreased
α1 NKA expression is involved with multiple disease states associated with metabolic
disturbances, including heart failure (Liu, Wu, & Kennedy, 2016), cancer (Banerjee et al., 2018;
Zhuang et al., 2015), diabetic neuropathy (Gerbi et al., 1998), and polycystic ovarian syndrome
(Tepavcevic et al., 2015). In contrast to α1 NKA, the expression of other mammalian isoforms
which do not signal through Src (α2, α3, and α4) is restricted to specific tissues (Blanco, 2005a).
In view of its links to mitochondrial ROS production and the highly conserved nature of Src
binding sites in mammalian ATP1A1, we postulate that the acquisition of Src binding sites in α1
NKA affords a fundamental regulatory mechanism of metabolic capacity, which supports
growth, endurance, and other physiological characteristics of endothermy. Conversely, it may
also represent a fundamental mechanism of metabolic dysregulation when animals are in a
chronic state of nutritional over-supply.
To test these hypotheses, we developed an in vitro system to compare the metabolic
profiles of cells expressing the wild-type Src binding α1 isoform, the wild-type non-Src binding
α2 isoform, a previously characterized loss-of-function Src binding mutant α1 isoform (Lai et al.,
2013), and a previously characterized Src binding, gain-of-function α2 mutant (Yu et al., 2018).
We then generated a mouse model with a skeletal muscle-specific ablation of ATP1A1, taking
advantage of the prior observation that the α2 isoform is the primary driver of ion-pumping
during skeletal muscle contraction (DiFranco et al., 2015). Moreover, in view of the well-
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established role of skeletal muscle in the regulation of glucose metabolism and insulin sensitivity
(Camps et al., 1992; DeFronzo & Tripathy, 2009; Holmstrom, Iglesias-Gutierrez, Zierath, &
Garcia-Roves, 2012; Honka et al., 2018; Koves et al., 2008; Meex et al., 2010; Neufer, Carey, &
Dohm, 1993; Son et al., 2017; Zurlo et al., 1990), we further utilized this model to address the
role of Src binding α1 NKA in the development of metabolic syndrome. These genetic studies
reveal a novel mechanism regulating metabolic reserve and flexibility. Moreover, they reveal a
trade-off phenotype of increased endurance at the cost of increased susceptibility to Western diet
and the consequent development of glucose intolerance and insulin resistance.

Results
The impact of Src binding sites in ATP1A1 on metabolic capacity in vitro.
Previous studies have identified two ATP1A1-specific Src binding sites (the NaKtide
sequence and Y260, Table 3) (Banerjee et al., 2018; Lai et al., 2013; Z. Li et al., 2009; Yu et al.,
2018) which are completely conserved within mammalian species. One of these binding sites,
the NaKtide sequence, also appears in birds, which evolved endothermy in parallel with
mammals. NaKtide contains 20 amino acid residues, the first ten of which (415S-424I) form a
helical structure important for Src binding (Lai et al., 2013). While ectothermic animals (Table
3) have amino acid substitutions that disrupt the formation of the helical structure (Lai et al.,
2013), most bird species contain one substitution (L419S/T) and a conserved substitution
(I424V). We therefore conclude that the Src binding function of NKA α1 is convergently
acquired in birds and mammals and coincides with the evolution of endothermy.
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Class

Species
Mouse α1
Rat α1
Pig α1
Whale α1
Dolphin α1
Bat α1
Chicken α1
Finch α1
Hummingbird α1
Eagle α1
Penguin α1
Bearded Dragon α1
King Cobra α1
Tiger Snake α1
Sea Turtle α1
Frog α1
Catfish α1
Herring α1
Freshwater Whipray α1
Zebrafish α1

255
255
253
253
253
253
253
253
224
254
224
224
253
257
256
255
224
258
250
256

Y260
RGIVVYTGDRT
RGIVVYTGDRT
RGIVVYTGDRT
RGIVVYTGDRT
RGIVVYTGDRT
RGIVVYTGDRT
VGIVISTGDRT
RGIVISTGDRT
RGIVISTGDRT
RGIVISTGDRT
RGIVISTGDRT
RGVVINTGDRT
RGVVINTGDRT
RGVVINTGDRT
RGVVINIGDNT
RGIVVNTGDRT
RGIVISTGDHT
RGIVISTGDKT
RGVVIFTGDRT
RGIVISTGDRT

265
265
263
263
263
263
263
263
234
264
234
234
263
267
266
265
234
268
260
266

415
415
413
413
413
413
413
413
384
414
384
284
414
417
416
415
384
418
410
416

NaKtide
SATWFALSRIAGLCNRAVFQ
SATWFALSRIAGLCNRAVFQ
SATWLALSRIAGLCNRAVFQ
SATWLALSRIAGLCNRAVFQ
SATWLALSRIAGLCNRAVFQ
SATWLALSRIAGLCNRAVFQ
SATWLALSRIAGLCNRAVFQ
SATWTALSRIAGLCNRAVFQ
SATWTALSRVAGLCNRAVFQ
SATWSALSRVAGLCNRAVFQ
SATWTALSRVAGLCNRAVFQ
SPTWTALARIAGLCNRAVFQ
SPTWTALAKIAGLCNRAVFQ
SPSWTALAKIAGLCNRAVFQ
SLTWVALSRVAGLCNRAVFQ
SPTWTALSRIAGLCNRAVFQ
SLTWTSLARIAGLCNRAVFL
SSTWSSLARIAGLCNRAVFL
SPTWSALSRIAALCNRAVFK
SATWASLARVAGLCNRAVFL

434
434
432
432
432
432
432
432
403
431
403
403
433
436
435
434
403
437
429
435

Mammals

Human α2
Mouse α2
Rat α2
Pig α2
Whale α2

253
253
253
253
253

RGIVIATGDRT
RGIVIATGDRT
RGIVIATGDRT
RGIVIATGDRT
RGIVIATGDRT

263
263
263
263
263

413
413
413
413
413

SPTWTALSRIAGLCNRAVFK
SPTWTALSRIAGLCNRAVFK
SPTWTALSRIAGLCNRAVFK
SPTWTALSRIAGLCNRAVFK
SPTWTALSRIAGLCNRAVFK

432
432
432
432
432

Insect

Drosophila α

273 KGVVISCGDHT 283

Mammals

Birds

Reptiles

Amphibia
ns
Fish

433 SPGFKALSRIATLCNRAEFK 452

Table 3: Conservation of the NKA α1/Src binding sites in mammals. Bold letters indicate
residues that differ from mammalian α1.
Sequences of Src binding regions of mammalian NKA α1 and homologous regions in other
classes of animals and in mammalian α2.
To assess the physiological significance of ATP1A1 Src binding, we generated 3 cell
lines from LLC-PK1, a porcine renal epithelial cell line, using a well-established knock down
and rescue approach (Liang et al., 2006; Liang et al., 2007). AAC-19 cells expressed wild-type
rat α1, LX-α2 cells expressed rat α2 that lacks the Src binding sites, and LY-a2 expressed a
mutant rat α2 that was engineered to contain both Src binding sites (Table 4). Western blotting
confirmed expression of these genes (Figure 13A). Detailed characterizations of these cell lines
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were previously reported (Lai et al., 2013; J. Xie et al., 2015; Yu et al., 2018), and revealed that
the expression of these transgenes further reduced the expression of endogenous pig α1 to an
undetectable level, making it possible to probe the properties of transgenes without interference
from the endogenous α1 NKA (Banerjee et al., 2018; Liang et al., 2006; Liu et al., 2006; J. Xie et
al., 2015; Yu et al., 2018) .
Cell Line
AAC-19
LX-α2
LY-a2
A420P

Isoform
Rat α1
Rat α2
Mutant α2
Mutant α1

Y260
255 RGIVVYTGDRT
253 RGIVIATGDRT
250 RGIVVYTGDRT
255 RGIVVYTGDRT

265
263
260
265

NaKtide
415 SATWFALSRIAGLCNRAVFQ
413 SPTWTALSRIAGLCNRAVFK
410 SATWFALSRIAGLCNRAVFQ
415 SATWPALSRIAGLCNRAVFQ

434
432
429
434

Table 4. Amino acid sequences of the Src binding sites of the WT rat α1, WT rat α2, and
gain-of-function signaling mutant α2 NKA expressed by the AAC-19, LX-α2, and LY-a2
cell lines.
Underlined letters indicate residues that have been changed in mutant α1 and α2, while bold
letters indicate residues that differ from wild-type rat α1.
In routine culture of these cells, we noted a rapid acidification of LX-α2 cells’ culture
medium (Figure 13B), which led us to compare glucose metabolism between these cell lines. As
depicted in Figure 11A, LX-α2 cells consumed nearly 2-fold more glucose than AAC-19 cells.
Interestingly, expression of the gain-of-function Src binding mutant α2 in LY-a2 cells restored
glucose consumption to the level of AAC-19 controls (Figure 11A). This was substantiated by
increased lactate production in LX-α2 compared to AAC-19 cells (Figure 11B), confirming that
the increase in glucose consumption correlated with an increase in aerobic glycolysis. Again,
LY-a2 cells exhibited a metabolic profile similar to that of control AAC-19 cells.
To identify whether α1 NKA-mediated regulation of Src is responsible for enhanced
metabolic flexibility and thus, a decreased reliance on glycolysis, cells were grown in glucosedeprived media and their proliferation was recorded. Both AAC-19 and LY-a2 cells, which
express a NKA capable of binding and regulating Src, were able to proliferate under glucosedeprived conditions. In contrast, LX-α2 cells failed to survive altogether (Figure 11C). To
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determine the degree to which LX-α2 cells were reliant upon glycolysis for ATP production, we
treated cells with increasing doses of the competitive glycolytic inhibitor 2-deoxy-D-glucose (2DG) and measured the impact of inhibited glycolysis on cellular ATP levels. At low
concentrations of 2-DG, only LX-α2 exhibited a significant decrease in cellular ATP (Figure
11D). These data reveal that the α1 NKA/Src interaction plays a key role in regulating metabolic
flexibility, but they do not address the question of metabolic reserve.

Figure 11: Importance of NKA α1 signaling for cell growth and metabolism.
A. Glucose consumption of AAC-19, LX-α2, and LY-a2 cells (n=6, ** p<0.01). B. Lactate
measured in the media of AAC-19, LX-α2, and LY-a2 cells after 72 hours cell growth (n=3, **
p<0.01, **** p<0.0001). C. Growth of AAC-19 (squares), LX-α2 (triangles), and LY-a2
(circles) cells in glucose-deprived media (n=6, ** p<0.01 vs AAC-19, **** p<0.0001 vs AAC19). D. ATP production in AAC-19, LX-α2, and LY-a2 cells in the presence of increasing
concentrations of the glycolysis inhibitor 2-DG (n listed at the base of each bar, * p<0.05 vs 0
mM 2-DG, **** p<0.0001 vs 0 mM 2-DG).
For this reason, we subjected these cells to Seahorse metabolic flux analyses (Figure 12).
When LX-α2 cells were subjected to the mitochondrial stress test, both basal and maximal
oxygen consumption rates were decreased (OCR, Figure 12B-C). Most significantly, a 65%
reduction in spare capacity (Figure 12D) was noted. On the other hand, LY-a2 cells displayed a
metabolic profile identical to that of α1-expressing AAC-19 cells. To probe whether the gain of
Src binding also affects glycolytic properties, we measured the extracellular acidification rate of
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LX-α2 cells (ECAR, Figure 12E). Although LX-α2 and AAC-19 cells exhibited similar basal
glycolysis levels, their maximum ECAR measured in the presence of oligomycin decreased. This
was in sharp contrast to AAC-19 cells in which ECAR increased (Figure 12F-G) and indicates a
complete loss of metabolic reserve in LX-α2 cells (Figure 12H). In all cases, LY-a2 cells
exhibited a metabolic profile identical to AAC-19 controls, indicating that the loss of metabolic
reserve and flexibility in the LX-α2 cells was due specifically to the lack of the Src binding and
not to other differences between the isoforms.

Figure 12: Seahorse metabolic analysis of AAC-19, LX-α2, and LY-a2 cells.
A. Representative trace of mitochondrial stress test of AAC-19 (squares), LX-α2 (triangles), and
LY-a2 (circles). B. Basal mitochondrial respiration of AAC-19 (n=30), LX-α2 (n=6), and LY-a2
(n=6). C. Maximum mitochondrial respiration of AAC-19 (n=30), LX-α2 (n=6), and LY-a2
(n=6). D. Spare respiratory capacity of AAC-19 (n=30), LX-α2 (n=6), and LY-a2 (n=6). E.
Representative trace of glycolytic stress test of AAC-19 (squares), LX-α2 (triangles), and LY-a2
(circles). F. Basal glycolysis rate of AAC-19 (n=30), LX-α2 (n=6), and LY-a2 (n=6). G.
Maximum glycolysis rate of AAC-19 (n=30), LX-α2 (n=6), and LY-a2 (n=6). H. Spare
glycolytic capacity of AAC-19 (n=30), LX-α2 (n=6), and LY-a2 (n=6). * p<0.05, ** p<0.01, ***
p<0.005, **** p<0.0001.
To assess the significance of acquiring the NaKtide sequence in birds, we measured both
OCR and ECAR parameters in cells expression a mutant α1 in which a mutation in the NaKtide
sequence (A420P) disrupts the NaKtide/Src interaction (Lai et al., 2013). In view of the fact that
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avian and mammalian NKA α1 contain highly or completely conserved NaKtide sequences
(Table 3), the evolutionary significance of this acquisition of Src binding was intriguing.
Because birds and mammals evolved separately (Figure 10), the acquisition of this Src binding
ability appears to be an example of convergent evolution between birds and mammals (Clarke &
Pörtner, 2010; Wu & Wang, 2019). To assess the significance of acquiring the NaKtide sequence
in birds, we measured both OCR and ECAR parameters in A420P cells, in which a mutation in
the NaKtide sequence (A420P) disrupts the NaKtide/Src interaction (Lai et al., 2013). As
depicted in Figure 14, loss of the NaKtide binding site in ATP1A1 significantly reduced
metabolic reserve and flexibility. It abolished spare capacity of ECAR and decreased OCR by
60%. However, although both A420P and LX-α2 cells lost reserve metabolic capacity in OCR
and ECAR, the loss in A420P cells, especially in ECAR, was less severe than that of LX-α2
cells. Additionally, there was no change in basal OCR and an increase in ECAR in A420P cells,
which was in sharp contrast to those of LX-α2 cells (Figure 14). These findings led us to
speculate that the acquisition of the Src binding site (NaKtide sequence) in birds facilitates the
generation of metabolic reserve and flexibility, which is a major characteristic of endothermy
(Clarke & Pörtner, 2010; Nespolo, Solano-Iguaran, & Bozinovic, 2017).

Figure 13: Characterization of renal epithelial-derived cell lines.
A. Western blot for α1 and α2 in AAC-19, LX-α2, and LY-a2 cells, as well as in the knock-down
PY-17 cells. B. Representative photos of media with no cells, AAC-19 cells, and LX-α2 after 24
hours of incubation.
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Figure 14: Seahorse metabolic analysis of cells expressing a loss-of-function Src bindingmutant NKA α1.
A. A representative trace of the mitochondrial stress test with AAC-19 (black, squares) and
A420P (grey, diamonds) cells. B. Spare mitochondrial capacity of AAC-19 (dark grey, squares)
and A420P (light grey, diamonds) cells. C. Representative trace of the glycolytic stress test with
AAC-19 (black, squares) and A420P (grey, diamonds) cells. D. Reserved glycolytic capacity of
AAC-19 (dark grey, squares) and A420P (light grey, diamonds) cells. (n=6-8, **p<0.01,
****p<0.001).
Generation of an in vivo mouse model.
To address the relevance of these findings in animal physiology, we used a
MyoDiCre/Lox system to develop a skeletal muscle-specific α1 NKA knockout mouse (skα1-/-)
as a model to assess the physiological significance of the α1 NKA/Src interaction in metabolic
regulation (Figure 15). Skeletal muscle was chosen as a model because it is a metabolically
dynamic tissue in which only 10% of NKA is the α1 isoform while the remaining 90% of NKA
is the non-Src-binding α2 isoform (He et al., 2001; J. Xie et al., 2015). In addition, prior
transgenic studies have documented that while skeletal muscle-specific knockout of α2 did not
affect skeletal muscle size or fiber type composition, the resulting deficits in K +-transport
abolished their ability to match force generation to contraction stimuli (DiFranco et al., 2015;
Manoharan et al., 2015; Radzyukevich et al., 2013). Given these results, the knockout of α1 was
expected to have a minimal effect on the pumping capacity of skeletal muscle. However, if α1
NKA signaling is a key regulator of metabolic capacity as demonstrated by Figures 1 and 2,
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genetic deletion of skeletal muscle α1 NKA would cause a switch to more glycolytic myofibers,
causing decreased exercise endurance.

Figure 15: Cre-Lox construct for the tissue-specific ablation of α1.
The ablation of α1 NKA in skα1-/- skeletal muscles was confirmed with both Western
blot and immunohistochemistry (Figure 16A-B). Expression of the α2 isoform was not changed
in skα1-/- mice compared with skα1+/+ controls (Figure 16A) and the total NKA activity of
crude membranes as measured by ouabain-sensitive ATPase activity was also unaffected (Figure
16C), indicating that the muscles maintained their Na+/K+ transport capacity.
Skα1-/- gastrocnemius muscles were more than 35% smaller than those of skα1+/+
control littermates (Figure 16D), revealing a role for α1 in growth in vivo that mirrors that
observed in vitro (J. Xie et al., 2015). This decrease in muscle mass was further confirmed in the
soleus (Figure 17). There was also a clear change in the ratio of oxidative to glycolytic muscle
fibers. Further histochemical analysis revealed proportionately more glycolytic type IIB fibers in
the skα1-/- white gastrocnemius muscle, with a corresponding decrease in the number of mixedoxidative type IIA fibers and a complete lack of oxidative type I fibers (Figure 16I). This fiber
type switch suggests a transition to a metabolism reliant on glycolysis consistent with the in vitro
cell culture data (Figures 1 and 2). Additionally, the number of fibers per muscle decreased in
skα1-/- muscles (Figure 16E), with a corresponding hypertrophy of Type IIB glycolytic fibers
(Figure 16F-G). This underscores the similarities between this animal model and the cell model

52

and further supports the notion of a shift from oxidative to glycolytic metabolism in skeletal
muscle of skα1-/- mice (J. Xie et al., 2015).

Figure 16: Development of skeletal muscle-specific NKA α1 KO mouse model.
A. Western blot for NKA α1 and α2 in skα1+/+ (n=8) and skα1-/- (n=10) muscles
(****p<0.0001). B. Immunohistochemistry of α1 and α2 in skeletal muscle. C. Ouabaininhibited ATPase activity in crude membrane fractions from skα1+/+ (n=3) and skα1-/- (n=4)
muscles. D. Gastrocnemius muscle size in skα1+/+ and skα1-/- male (n=5 and n=6, respectively)
and female (n=11 and n=9, respectively) mice. (**** p<0.0001). E. Myofiber number in skα1-/white gastrocnemius muscles. F. Representative micrographs of skα1-/- and skα1+/+ white
gastrocnemius muscles. Blue arrows indicate type IIB and black arrows indicate type IIa fibers.
G. Mean cross sectional areas of type IIa and type IIb fibers. H. Histogram of fiber CSA. I.
Proportion of fibers which are type IIa, type IIb, and type 1.
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Figure 17: Soleus mass in 16-week-old skα1+/+ (grey, squares) and skα1-/- (white,
triangles) mice.
Impact of metabolic deficits in skα1-/- muscles on exercise performance.
Though the fiber type switch suggested a more glycolytic metabolism in skα1-/- muscles,
we needed to determine the impact on muscle metabolism and performance. In a treadmill test at
speeds up to 25 m/min, skα1-/- ran as well as skα1+/+ controls (Figure 18A), which contrasts
sharply with the phenotype observed in the α2 knockout mouse (DiFranco et al., 2015;
Manoharan et al., 2015; Radzyukevich et al., 2013). However, skα1-/- mice showed a 50%
reduction in endurance as measured by distance to fatigue (Figure 18B), which suggests a lack of
oxidative metabolic capacity and an inability to adapt to changing metabolic demands during
exercise (Baker et al., 2010; Overmyer et al., 2015). Biochemically, we observed a 50% decrease
in muscle glycogen content in skα1-/- gastrocnemius muscles compared to skα1+/+ mice, which
could contribute to their decreased endurance (Figure 18C). Furthermore, GSK3β expression in
the gastrocnemius of skα1-/- mice was significantly increased whereas the level of inhibitory
phosphorylated serine 9 (pS9) was not affected (Figure 18D-E). Thus, it is most likely that the
decreased amount of glycogen in skα1-/- gastrocnemius is due to the inhibition of glycogen
synthesis rather than an accelerated use of glycogen by the muscle.
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Figure 18: Exercise capacity of skα1-/- mice.
A. Number of shocks administered per minute per mouse at each treadmill speed to skα1+/+
(squares, n=17) and skα1-/- (triangles, n=16) mice. B. Maximum distance run by skα1+/+ (grey,
squares) and skα1-/- (white, triangles) male (n=10 and 17, respectively) and female (n=16 and
11, respectively) mice. (*p<0.05, ****p<0.0001). C. Glycogen content of gastrocnemius
muscles from male skα1+/+ (grey, squares) and skα1-/- (white, triangles) mice (n=5-6, *p<0.05).
D. Representative Western blot for phosphorylated and total glycogen synthase kinase 3β. E.
Quantification of Western blots for phosphorylated and total glycogen synthase kinase 3β in
skα1+/+ (grey, squares) and skα1-/- (white, triangles) gastrocnemius muscles (n=5-6, **p<0.01).
RNA sequencing analyses of metabolic defects and transcriptional regulation of key
metabolic genes.
To use an unbiased approach to probe for changes in signaling pathways involved in the
regulation of skeletal muscle, we conducted RNA sequencing analyses of skα1-/- gastrocnemius
muscles. As depicted in the heat map in Figure 19A, several groups of genes were altered in
gastrocnemius of skα1-/- mice. We further analyzed the Gene Ontology enrichment of
differentially expressed genes and visualized the result in a network map by Cytoscape. (Fig
19B). The analyses revealed changes in signaling pathways related to cell metabolism, ROS
production via changes in oxygen and hypoxia sensing, protein assembly, cytoskeleton
organization, and cell differentiation and morphogenesis.
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Figure 19: Analysis of mRNA expression of metabolic genes in renal epithelial cells and
skeletal muscles.
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A (pg 56). Heatmap of differentially expressed genes identified by RNA sequencing of skα1+/+
and skα1-/- gastrocnemius muscles. B (pg 56). Map of pathways including differentially
expressed genes identified by RNA sequencing of skα1+/+ and skα1-/- gastrocnemius muscles.
C-E. Expression of Ppargc1a (C), Atp5a1 (D), and Acadm (E) in skα1+/+ (grey, squares, n=4)
and skα1-/- (white, triangles, n=4) white gastrocnemius muscles. F-H. Expression of Hk2 (F),
Pkm (G), and Pfkm (H) in skα1+/+ (grey, squares, n=4) and skα1-/- (white, triangles, n=4) white
gastrocnemius muscles. I-K. Expression of Ppargc1a (I), Atp5a1 (J), and Mcad (K) in AAC-19
(dark grey, squares, n=6), LY-α2 (white, triangles, n=6), and LY-a2 (light grey, circles, n=6)
cells. L-N. Expression of Hk2 (L), Pkm (M), and Pfkm (N) AAC-19 (dark grey, squares, n=6),
LY-α2 (white, triangles, n=6), and LY-a2 (light grey, circles, n=6) cells.
We then explored the transcriptional regulation of metabolic genes in skα1-/- and
skα1+/+ muscles. Skα1-/- gastrocnemius muscles exhibited decreased expression of the master
regulator of mitochondrial biogenesis, Ppargc1a (peroxisome proliferator activated receptor γ
coactivator 1α, PGC-1α) (Figure 19C). Similarly, expression of Atp5a1 (ATP synthase F1
subunit α) and Acadm (medium-chain acyl-CoA dehydrogenase) was decreased in skα1-/gastrocnemius muscles (Figure 19D-E). Additionally, expression of the key glycolytic enzymes
Hk2 (hexokinase 2), Pkm (pyruvate kinasr), and Pfkm (phosphofructo kinase was decreased in
skα1-/- muscles compared to skα1+/+ muscles (Figure 19F-H). These data are further evidence
of an overall decrease in metabolic capacity in skα1-/- gastrocnemius muscles.
To further determine whether the metabolic defects observed in our in vitro studies and
those suggested by the phenotype of skα1-/- mice could have similar transcriptional mechanisms,
we analyzed the mRNA expression of the same metabolic genes in AAC-19, LX-α2, and LY-a2
cells. Similar to our observations in skα1-/- muscles, expression of the mitochondrial
metabolism-related genes Ppargc1a, Atp5a1, and Acadm were down-regulated in LX-α2 cells
compared to AAC-19 cells, and these defects were partially restored in LY-a2 cells (Figure 19IK). In contrast, although expression of Pfkm was decreased in LX-α2 cells, we observed no
change in Hk2 or Pkm expression in LX-α2 cells (Figure 19L-N). In contrast to the
mitochondrial genes, LY-a2 expression did not rescue expression of Pfkm (Figure 19N). The
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similarities in expression of key oxidative metabolic genes between the renal epithelial cells and
skα1-/- muscles suggest a similar molecular mechanism underlying the regulation of
mitochondrial metabolism in both models. In contrast, the differences in the expression pattern
of the glycolytic genes in skα1-/- muscle and LX-α2 cells suggest distinct regulation of
glycolysis in these systems.

Figure 20: Oxidative stress and antioxidant response in skα1-/- mice on Western diet.
A-D. Expression of Nrf2-related genes in gastrocnemius muscles from skα1+/+ (grey, squares)
and skα1-/- (white, triangles) mice on normal chow (NC, filled symbols) and Western diet (WD,
open symbols): Nuclear factor erythroid 2-related factor 2 (Nfe2l2, A), heme oxygenase 1
(Hmox1, B), NAD(P)H quinone dehydrogenase 1 (Nqo1, C), and glutathione S-transferase mu 1
(Gstm1, D) (n=4-6, *p<0.05, **p<0.01, ***p<0.005). E. Change in protein carbonylation in
gastrocnemius muscles from skα1+/+ (grey, squares) and skα1-/- (white, triangles) mice on
normal chow (NC, filled symbols) and Western diet (WD, open symbols) relative to NC controls
(n=4-5, *p<0.05, ***p<0.005). F-I. Expression of cytokines in the livers of skα1+/+ (grey,
squares) and skα1-/- (white, triangles) mice on normal chow (NC, filled symbols) and Western
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diet (WD, open symbols): monocyte chemoattractant protein 1 (Ccl2, F), tumor necrosis factor α
(Tnfa, G), interleukin 6 (Il6, H), and interleukin 1b (Il1b, I). J-L. Expression of Nrf2-related
genes in livers of skα1+/+ and skα1-/- mice on NC (grey) and WD (white): Nuclear factor
erythroid 2-related factor 2 (Nfe2l2, J), heme oxygenase 1 (Hmox1, K), and NAD(P)H quinone
dehydrogenase 1 (Nqo1, L). M. Representative images of haematoxylin and eosin stained livers
from skα1+/+ and skα1-/- mice fed NC or WD showing no clear evidence of steatosis. N.
Expression of the cytokine tumor necrosis factor α (Tnfa) in visceral epidydimal adipose from
skα1+/+ (grey, squares) and skα1-/- (white, triangles) mice on normal chow (NC, filled symbols)
and Western diet (WD, open symbols). O. Expression of the Nrf2-related heme-oxygenase 1
(Hmox1) in visceral epidydimal adipose from skα1+/+ (grey, squares) and skα1-/- (white,
triangles) mice on normal chow (NC, filled symbols) and Western diet (WD, open symbols).
Skeletal muscle α1 and susceptibility to diet-induced metabolic dysfunction.
The above findings suggest that the acquisition of Src binding sites in ATP1A1 facilitates
increased metabolic capacity in endotherms, which is consistent with the aerobic scope
hypothesis of endotherm evolution (Clarke & Pörtner, 2010; Nespolo et al., 2017). On the other
hand, this gain of metabolic reserve and flexibility may become a liability when mammals are
fed a high-fat, high-fructose Western diet (WD), which increases pathological ROS stress,
promotes tissue inflammation, and causes metabolic syndrome. Since skeletal muscle plays an
important role in both glucose homeostasis and metabolic flux (Honka et al., 2018; Zurlo et al.,
1990), this prompted us to test whether expression of ATP1A1 links the benefits of enhanced
muscle metabolic capacity and endurance to increased susceptibility to diet-induced metabolic
dysfunction, specifically the development of glucose intolerance and insulin resistance.
Therefore, we subjected skα1-/- mice to WD to observe how they adapted to the metabolic stress
of chronic overnutrition (Sodhi et al., 2015). Baseline body mass and body composition were
similar between skα1-/- and skα1+/+ mice assigned to normal chow (NC) or Western diet (WD)
(data not shown). Due to their FVB-dominant mixed-strain background, even wild-type controls
gained less weight than C57Bl6 mice on the same diet, a result of the well-documented FVB
resistance to obesity (Nascimento-Sales et al., 2017). However, tissues collected after 12 weeks
of WD revealed a significant increase in epidydimal and subcutaneous adipose tissues in control
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skα1+/+ mice (Figure 21A-B). In contrast, although WD produced a modest increase in both fat
tissues in skα1-/- mice, the apparent increase did not reach statistical significance (Figure 21A-B,
p=0.4).

Figure 21: Impact of skeletal muscle-specific ablation of NKA α1 on reaction to Western
diet.
A. Epidydimal fat pad mass to body weight (BW) ratio in skα1+/+ (grey) and skα1-/- (white)
mice after 12 weeks on a Western diet (WD) or normal chow (NC) (skα1+/+ NC n=8, skα1 WD
n=14, skα1-/- NC n=4, skα1-/- WD n=12). B. Subcutaneous fat pad (SubQ)/BW ratio in skα1+/+
(grey) and skα1-/- (white) mice after 12 weeks on WD or NC (skα1+/+ NC n=8, skα1 WD n=14,
skα1-/- NC n=4, skα1-/- WD n=12). C. Liver mass to BW ratio in skα1+/+ (grey) and skα1-/(white) mice after 12 weeks on a WD or NC (skα1+/+ NC n=8, skα1 WD n=14, skα1-/- NC n=4,
skα1-/- WD n=12). D. Fasting blood glucose in skα1+/+ (grey) and skα1-/- (white) mice after 12
weeks on WD or NC (skα1+/+ NC n=4, skα1 WD n=5, skα1-/- NC n=4, skα1-/- WD n=4). E.
Glucose tolerance test and area under the curve of skα1-/- and skα1+/+ mice after 6 weeks on
Western diet (skα1+/+ NC n=7, skα1 WD n=6, skα1-/- NC n=4, skα1-/- WD n=4). F. Insulin
tolerance test of skα1-/- and skα1+/+ mice after 12 weeks on Western diet (skα1+/+ NC n=4,
skα1 WD n=5, skα1-/- NC n=4, skα1-/- WD n=4). (* p<0.05, ** p<0.01, **** p<0.0001)
Since activation of the α1 NKA/Src is associated with increased ROS production and
ROS stress is central to the development of diet-induced metabolic dysfunction, we measured the
activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, which increases the
expression of antioxidant enzymes on a WD (Devarshi, McNabney, & Henagan, 2017). As
depicted in Figure 20, WD not only increased Nrf2 expression (Nfe2l2, Figure 20A) but also
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increased the mRNA expression of the Nrf2 targets heme oxygenase 1 (Hmox1) and NAD(P)H
quinone dehydrogenase 1 (Nqo1) (Figure 20B-C), indicating that WD-induced ROS stress
elicited a robust antioxidant response in skα1+/+ muscles. This conclusion was further
strengthened by the induction of glutathione S-transferase mu 1 (Gstm1) (Figure 20D). In
contrast, no changes in the expression of these genes were observed in the gastrocnemius of
skα1-/- mice, suggesting that the ablation of α1 attenuates ROS stress, consistent with what has
been reported (Yan et al., 2013). To further assess ROS signaling, we also measured protein
carbonylation, an indicator of an increase in H2O2. As depicted in Figure 20E, a comparable
increase in protein carbonylation was noted in both skα1-/- and skα1+/+ mouse gastrocnemius.
In addition to skeletal muscle, liver plays a critically important role in the progression of
metabolic syndrome, with WD-induced inflammation and oxidative stress leading to nonalcoholic steatohepatitis (NASH) and compensatory activation of the Nrf2 pathway and
antioxidant responses (D. Xu et al., 2018). Therefore, we examined expression of Nrf2-targeted
genes, cytokine expression, and liver morphology for evidence of oxidative stress, inflammation,
and ultimately NASH. We found that the expression of the inflammatory cytokines monocyte
chemoattractant protein 1 (Ccl2), tumor necrosis factor α (Tnfa), and interleukin 6 (Il6) was
highly induced in the livers of control skα1+/+ mice (Figure 20F-H). In sharp contrast, these
changes in the liver were blunted in skα1-/- mice. As depicted in Figure 20J, there was no
increase in Nfe2l2 expression, and induction of Hmox1 expression did not reach statistical
significance (Figure 20K). However, expression of Nqo1 increased in skα1+/+ WD livers but not
in skα1-/- WD livers (Figure 20L), suggesting that skα1+/+ WD mice had begun the process of
developing NASH but had not developed the severity seen in C57J/BL6 mice on the same diet
(Sodhi et al., 2017). In accordance, there was no evidence of morphological changes in the liver
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histology (Figure 20M), which is consistent with the unaltered liver weight/body weight ratio in
both skα1-/- and skα1+/+ mice on WD (Figure 21C).

Figure 22: Pharmacological targeting of α1 NKA signaling through Src in diet-induced
metabolic dysfunction.
A. Weight gain in C57J/BL6 over 12 weeks of WD or NC with pNaKtide injection or vehicle
injection. (n=10, ##p<0.01, ### p<0.005, #### p<0.0005 NC+Vehicle vs WD+Vehicle; * p<0.05, **
p<0.005 WD+Vehicle vs WD+pNaKtide) B. Effects of pNaKtide on body composition after 12
weeks WD. C-F. Hepatic expression of F4/80 (C.), Ccl2 (D.), Tnfa (E.), and Hmox1 (F.) after
12 weeks diet treatment. G. Representative micrographs of liver sections stained with H&E to
show lipid accumulation. (n=6, * p<0.05, ** p<0.01, *** p<0.005, **** p<0.0005)
To complement the above studies, we repeated the above qPCR measurements of
inflammatory cytokines and Nrf2-targeted genes in the epidydimal fat pad, another important
tissue in the development of glucose intolerance and insulin resistance. Interestingly, the
expression of Tnfa was comparably induced in both skα1+/+ and skα1-/- epidydimal fat (Figure
20N), although expression of other cytokines was unchanged (data not shown). When the Nrf2
pathway was evaluated, WD increased expression of Hmox1 three-fold in the epidydimal fat of
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skα1+/+ but not skα1-/- mice (Figure 20O). However, unlike in skeletal muscle, WD did not
alter the expression of other Nrf2-targeted genes (data not shown).
To further probe the impact of skα1-/- on the development of metabolic syndrome, we
measured fasting blood glucose and conducted glucose tolerance tests (GTT) and insulin
tolerance tests (ITT). As depicted in Figure 21D, after 12 weeks of WD, fasting glucose was
significantly elevated only in WD-fed skα1+/+ mice. A GTT administered after 6 weeks of WD
showed increased glucose intolerance as measured by the area under the curve (AUC) only in
skα1+/+ mice, while WD-fed skα1-/- mice maintained normal glucose clearance (Figure 21E).
An ITT administered after 12 weeks revealed impaired insulin sensitivity in skα1+/+ mice but
not in skα1-/- mice fed with WD as measured by AUC (Figure 21F). In both cases, glucose
clearance was not different between skα1+/+ and skα1-/- mice fed with normal chow but was
significantly decreased in skα1+/+ mice compared to skα1-/- mice fed with WD (Figures 7E-F).
Pharmacological interruption of α1 NKA/Src binding attenuates the progression of
non-alcoholic steatohepatitis.
The above metabolic protection afforded by the genetic deletion of ATP1A1 in skeletal
muscle provides compelling evidence for a role of α1 NKA-mediated Src signaling in developing
diet-induced hepatic inflammation and oxidative stress, which ultimately leads to the
development of NASH. To further test this hypothesis, and to evaluate whether pNaKtide, a
peptide derived from α1 NKA that blocks the formation of the α1 NKA/Src complex, could be
developed as a drug candidate for NASH, we treated WD-fed C57J/Bl6 mice with 5 mg/kg
pNaKtide every other day. This treatment resulted in a significant decrease in weight gain and
moderately improved body composition (Figure 22A-B). Like skα1-/-, pNaKtide treatment
attenuated liver inflammation, normalizing the expression of Ccl2, Tnfa, and the macrophage
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marker F4/80 (Figure 22C-E). Furthermore, pNaKtide abolished the induction of the Nrf-2 target
gene Hmox1 was decreased (Figure 22F). Finally, pNaKtide protected livers from WD-induced
hepatic steatosis (Figure 22G). Because the no-observable-effect level of pNaKtide in mice is 25
mg/kg/day, we conclude from these findings that pNaKtide, by disrupting the formation of α1
NKA/Src complex, is not only effective in blocking WD-induced ROS stress, inflammation, and
preventing the progression of NASH, but is also well-tolerated.
Discussion
In this study, we have made three important observations. First, we report for the first
time that the evolutionary acquisition of Src binding in α1 NKA facilitates increased metabolic
capacity. This represents a hitherto unidentified regulatory mechanism, most likely an important
evolutionary event impacting endotherm physiology. It also illustrates how the NKA gained
additional fundamental functions during the evolutionary process and provides molecular
insights into NKA isoform heterogeneity. Second, we were able to demonstrate the metabolic
importance of the α1 isoform in an in vivo model. The ablation of α1 NKA caused a switch from
oxidative to glycolytic muscle and a significant hypertrophy of glycolytic Type IIB fibers in
gastrocnemius muscles (Figure 16). Consequently, it significantly reduced endurance.
Paradoxically, it also afforded protection against diet-induced glucose intolerance and insulin
resistance by reducing ROS stress and inflammation in three vital metabolic tissues. Therefore, it
is reasonable to propose that mammals’ enhanced metabolic reserve and flexibility and their
susceptibility to WD-induced metabolic stress are triggered by a common mechanism – α1
NKA-mediated Src regulation. Finally, these new findings, taken together with previous reports
on the in vivo efficacy of pNaKtide in metabolic syndrome, validate the α1 NKA/Src interaction
as a novel therapeutic target for metabolic syndrome.
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The evolutionary nature of NKA signaling and its significance in animal physiology.
In addition to the Src binding sites, we have also identified a caveolin binding motif in
the α subunit of NKA, which is conserved in all NKA α subunits within the animal kingdom
(unpublished data). Recent studies demonstrate that loss of the caveolin binding motif causes the
arrest of stem cell differentiation and organogenesis in mammals and C. elegans (unpublished
data). Thus, NKA evolved with multiple functionalities. Though all animal α isoforms contain
the caveolin motif, Src binding is confined to endotherms, with birds possessing only the
NaKtide sequence and mammals possessing both NaKtide and Y260 sequences (Table 3).
Although the current work focused on the Src signaling role of ATP1A1, the possibility that
other NKA isoforms have acquired other binding motifs that confer additional tissue and cellspecific functions that are independent of ion pumping should be considered.
It is important to recognize the unique nature of ATP1A1 signaling through Src for
regulating metabolic capacity in mammalian cells. Specifically, our gain-of-Src-binding and
loss-of-Src-binding studies indicate that the acquisition of Src binding by α1 NKA is essential
for generating metabolic reserve (Figure 12). This contrasts with other recognized pathways such
as PPARγ (Rodriguez-Cuenca et al., 2012), PGC-1α (Andrzejewski et al., 2017), AMPK
(Schonke, Massart, & Zierath, 2018), and pyruvate dehydrogenases (S. Zhang, Hulver,
McMillan, Cline, & Gilbert, 2014), which play important but nonessential roles in the generation
of metabolic reserve. Similarly, NKA/Src interaction increased metabolic flexibility (Figures 1
and 2). Together, these metabolic changes represent a significant increase in metabolic capacity,
allowing locomotive endurance, which the aerobic scope hypothesis posits was a selective driver
for the evolution of endothermy from ectothermy (Clarke & Pörtner, 2010; Nespolo et al., 2017).
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Further, we demonstrated that the skeletal muscle-specific knockout of α1 produced a
phenotype unique from the skeletal muscle-specific knockout of α2 (skα2-/-), which is the
primary isoform necessary for the maintenance of skeletal muscle contraction, especially at high
stimuli frequencies (DiFranco et al., 2015; Manoharan et al., 2015; Radzyukevich et al., 2013).
This difference between skα1-/- and skα2-/- phenotypes supports the hypothesis that the α1
isoform, and most likely its Src binding function, is responsible for the regulation of metabolic
capacity. This was represented by the switch to more glycolytic muscle fibers (Figure 16I) and
the decreased endurance (Figure 18A) in skα1-/- mice. Thus, we speculate that the evolution of
Src binding in birds and mammals may have increased metabolic reserve and flexibility, which
the aerobic scope hypothesis posits were necessary for the evolution of endothermy (Nespolo et
al., 2017).
Notably, both Src binding sites appear to be important for regulating metabolic capacity.
In addition to the cell lines used in this study (LX-α2, LY-a2, AAC-19, and A420P), we also
created a cell line expressing a Y260A mutant rat α1. The impact of the Y260A mutation on
metabolic reserve and flexibility appears to be the mildest (Banerjee et al., 2018), followed by
the A420P mutation and, finally, the complete loss of Src binding sites in the LX-α2 cell line.
NKA/Src interaction as a molecular target for developing therapeutics for metabolic
syndrome.
The first evidence linking α1 NKA to ROS production came from our early studies of
cardiotonic steroids in cultures of cardiac myocytes (Z. Xie et al., 1999). Subsequently, we
documented that stimulation of the α1 NKA/Src receptor complex by cardiotonic steroids
increased ROS production in multiple cell types via both mitochondria and NADPH oxidase
activation (Banerjee et al., 2018; Liu et al., 2006; Sodhi et al., 2015; Sodhi et al., 2018; Sodhi et

66

al., 2017; Z. Xie et al., 1999; Yan et al., 2013). These ROS then stimulate the α1 NKA/Src
complex, forming an amplification loop for the pathological production of ROS (Yan et al.,
2013). Targeting the α1 NKA/Src interaction with pNaktide, a peptide inhibitor of the signaling
complex (Z. Li et al., 2009), terminates this amplification loop, thereby preventing the generation
of pathological ROS stress (Z. Li et al., 2009). These in vitro studies were further supported by
recent in vivo animal studies (H. Li et al., 2018; Sodhi et al., 2015; Sodhi et al., 2017).
Administration of pNaKtide restored insulin sensitivity and glucose tolerance in animals
subjected to WD (Sodhi et al., 2015; Sodhi et al., 2017; Srikanthan et al., 2016). However, it is
important to note that pNaKtide was used at 25 mg/kg/week in these in vivo studies. Because the
no-observable-effect level of pNaKtide in mice is 25 mg/kg/day, these studies failed to address
the safety and drug development potential of pNaKtide.
The skα1-/- phenotype provides strong genetic evidence for a role of α1 NKA/Src
interaction in the development of diet-induced insulin resistance, glucose intolerance, and liver
inflammation (Figures 6-7). These findings, taken together with the pharmacological studies of
pNaKtide, validate the α1 NKA/Src interaction as a molecular target for the development of new
therapeutics for metabolic syndrome. Moreover, the new pharmacological studies of pNaKtide at
a much lower dose (5 mg/kg vs 25 mg/kg) provided compelling evidence of the potency and
efficacy of pNaKtide in blocking liver ROS stress, inflammation, and the progression of NASH
without the concern of significant side effects. Interestingly, our new findings indicate that the
loss of α1-mediated Src signaling in skeletal muscle is sufficient to confer systemic protection
from diet-induced glucose intolerance and insulin resistance and reduce oxidative stress and
inflammation in target organs. These protective effects appear to be organ-specific, with most of
the protection afforded to the liver. In view of the demonstrated role of cross-talk between
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skeletal muscle, liver, and adipose, it is reasonable to suggest that skeletal muscle-specific
delivery of pNaKtide might be sufficient to produce therapeutic benefits in metabolic syndrome.
This will further reduce the potential of pNaKtide-induced systemic effects.
In addition to ROS stress and inflammation, the potential contribution of elevated GSK3β expression in skα1-/- mouse skeletal muscles should be considered. High GSK-3β expression
is not only consistent with the detected decrease in muscle glycogen content (Figure 18C), but
could provide one of many links between the metabolic defects and decreased growth in skα1-/muscles (Figure 16) (van der Velden et al., 2007). In addition to protecting skα1-/- mice from
WD-induced insulin resistance (Figure 21), the absence of α1 NKA caused a significant decrease
in muscle mass (Figure 16D), a switch to glycolytic muscle fibers, and a 50% decrease in
running endurance (Figure 18B), all of which could be a result of decreased metabolic capacity
(Baker et al., 2010; Overmyer et al., 2015). Therefore, we propose that the evolutionary
acquisition of Src binding sites in ATP1A1 came with a tradeoff: the increased metabolic reserve
and flexibility enhanced mitochondrial metabolism and increased exercise endurance came at the
cost of increased susceptibility to diet-induced glucose intolerance and insulin insensitivity.
Interestingly, this idea that both improved mitochondrial efficiency and severely reduced
mitochondrial capacity can preserve glucose homeostasis in the face of a WD has been proposed
before (Finck et al., 2005; Koves et al., 2008), with Koves et al. postulating that incomplete βoxidation of lipids rather than the lipids themselves leads to lipotoxicity-induced insulin
resistance, a possibility that still needs to be explored in our models. Together, these new
findings reveal α1 NKA signaling through Src as a novel regulator for generating metabolic
reserve and flexibility in mammals as well as a validated drug target. Furthermore, this offers a
novel explanation for exercise-induced increases in α1 NKA expression (Murphy, Petersen, et
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al., 2006; H. Xu et al., 2018). This hypothesis is further supported by the reports that individuals
with natural running ability have high basal levels of α1 in skeletal and cardiac muscle (Chen et
al., 2001; Mohr, Thomassen, Girard, Racinais, & Nybo, 2016).
Limitations.
We recognize that there are a number of important unanswered questions. Decreased α1
expression has been shown to decrease muscle size in a different mouse model (Kutz et al.,
2018), but the growth pathways have yet to be identified. It is also important to note that in
addition to skeletal muscle, other cells such as cardiomyocytes, adipocytes, and glial cells also
express both α2 and α1 NKA. Thus, it remains to be investigated whether ablation of α1 also
causes a metabolic switch and reduced functionality in these cells. Moreover, although our in
vitro studies of metabolic profile of A420P mutant α1 support the contention that the acquisition
of NaKtide sequence by birds would most likely impact their metabolic reserve and flexibility,
this postulation remains to be experimentally tested. Finally, because the skα1-/- mice were
generated on a dominant FVB mixed-strain background, which caused them to accumulate less
fat mass than C57BL6 mice fed a WD (Figure 22), we recognize that the genetic background of
our transgenic animal model may influence or limit our conclusions about the impact of skeletal
muscle α1 ablation on the development of metabolic syndrome (Nascimento-Sales et al., 2017;
Sodhi et al., 2017).
Additionally, there are a few contradictions between the skα1-/- phenotype and the
current accepted links between increased running endurance to better health outcomes, including
improvements in insulin sensitivity and glucose tolerance (Baker et al., 2010; Overmyer et al.,
2015). The association between severely attenuated mitochondrial metabolism and decreased
susceptibility to diet-induced metabolic dysfunction is, however, consistent with the hypothesis
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that incomplete β oxidation of lipids and not the lack of mitochondrial metabolism is responsible
for insulin resistance (Finck et al., 2005; Koves et al., 2008). Moreover, the lack of exercise
endurance in skα1-/- mice is consistent with studies that have clearly demonstrated a correlation
between increased exercise endurance and α1 NKA expression in the muscle of inbred rats
(Chen et al., 2001).
In short, the data presented here describe a common mechanism underlying the following
dichotomy: the generation of metabolic reserve and flexibility in the muscle, and consequently
exercise endurance, comes at the cost of metabolic intolerance to a Western diet. These new
molecular insights, together with the findings from previous studies utilizing pNaKtide, validate
the α1 NKA/Src interaction as a novel molecular target for the development of new
pharmacological approaches to treating metabolic disorders. To this end, our new
pharmacological studies warrant further development of pNaKtide and its derivatives as drug
candidates for NASH and other metabolic disorders.
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Materials and Methods
Reagents.
The polyclonal anti-NKA α1 antiserum NASE and polyclonal anti-NKA α2 antiserum
HERED used for Western blots were raised in rabbits and were generous gifts from Drs. T.
Pressley and P. Artigas at Texas Tech University Health Sciences Center (40). Anti-α tubulin
antibody (Sigma, catalog number T5168) was used as a loading control. Secondary antibodies
were horseradish peroxidase-conjugated anti-rabbit and anti-mouse from Santa Cruz
Biotechnology Inc (catalog number sc-2004 and sc-2005, respectively).
Cell Culture.
The parental LLC-PK1 cells were purchased from ATCC.
Site-directed mutagenesis and generation of mutant-rescued stable cell lines.
Mutant cell lines used in this work were derived from LLC-PK1 cells. The generation of
α1 NKA knock down PY-17 cells from LLC-PK1 was well described (Liang et al., 2006). PY-17
cells express about 8% of α1 NKA in comparison to that in LLC-PK1 cells, and do not express
other isoforms of NKA. Using the well-established protocol of knockdown and rescue, we have
generated a number of stable cell lines (Lai et al., 2013; J. Xie et al., 2015; Yan et al., 2013). The
generation and characterization of the α1-rescued AAC-19 cells, α1 mutant-rescued A420P, α2rescued LX-α2, and α2 mutant-rescued cells used in this study have been reported (Lai et al.,
2013; Liang et al., 2006; J. Xie et al., 2015; Yu et al., 2018). After cells reached 95-100%
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confluence, they were serum-starved overnight and used for experiments unless indicated
otherwise. All cell lines were cultured in DMEM plus 10% FBS with 1%
penicillin/streptomycin.
Cell Growth Assay.
Cell growth assay was performed as previously described (Liang et al., 2007). Briefly,
20,000 cells/well were seeded in triplicates in 12-well plates in glucose-free DMEM containing
10% FBS and 1% penicillin/streptomycin. Cells were serum-starved for at least 12 hours to
achieve cell cycle synchronization. At indicated time points, cells were trypsinized, and the
number of cells was counted with hemocytometer.
Biochemical measurement of ATP and lactate.
ATP measurements were performed using CellTiter-Glo Luminescent Cell Viability
Assay Kit (Promega, Madison, WI, USA, Cat # G7570). According to the protocol provided by
the manufacturer, 10,000 cells per well were cultured in 96-well culture plate. After treatment
with 2-DG (Sigma-Aldrich, Cat# D6134) at indicated concentrations in serum-free DMEM for
45 minutes, assay reagents were reconstituted and added into culture plate. Afterwards, reactants
were transferred to opaque-walled 96-well plate, and luminescent counts were determined with
microplate reader.
Lactate measurement was done as described by Barker (Barker & Summerson, 1941).
Media glucose depletion.
Media was collected from cells after 3 days incubation. Glucose concentration in the
media was measured using a Glucose Colorimetric Assay Kit from Cayman Chemical (Item no.
10009582, Ann Arbor, Michigan, USA). Glucose concentrations were subtracted from the
glucose concentration in fresh media to determine media glucose depletion by each cell line, and
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then normalized to AAC-19 controls for each experiment, so that the final number from each
experiment was derived from the following equation:
𝑓𝑜𝑙𝑑𝑠 𝑡𝑜 𝐴𝐴𝐶 − 19 =

[𝑔𝑙𝑢𝑐𝑜𝑠𝑒𝑓𝑟𝑒𝑠ℎ 𝑚𝑒𝑑𝑖𝑎 ] − [𝑔𝑙𝑢𝑐𝑜𝑠𝑒𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 𝑚𝑒𝑑𝑖𝑎 ]
[𝑔𝑙𝑢𝑐𝑜𝑠𝑒𝑓𝑟𝑒𝑠ℎ 𝑚𝑒𝑑𝑖𝑎 ] − [𝑔𝑙𝑢𝑐𝑜𝑠𝑒𝐴𝐴𝐶−19 𝑚𝑒𝑑𝑖𝑎 ]

Cell proliferation in glucose-deprived media.
Cells were plated and grown in media consisting of glucose-free DMEM, 10% FBS, and
1% Penicillin/Streptomycin, and cell number was counted after 0, 24, 36, and 48 hours of
proliferation.
Seahorse metabolic flux analysis.
Cells were plated in Seahorse XFp cell culture plates and subjected to both the
mitochondrial stress test (Agilent Technologies, Cat # 103010-100) and the glycolytic stress test
(Agilent Technologies, Cedar Creek, TX, US, Cat #103017-100) supplied by the manufacturer,
with the injection of oligomycin, trifluoromethoxy carbonylcyanide phenylhydrazone (FCCP),
rotenone and antimycin A, glucose, and 2-deoxyglucose (2-DG), as described in Table S3. Three
measurements of oxygen consumption rate and extracellular acidification rate were taken at
baseline and after each injection. The appropriate concentration of FCCP was determined by
FCCP titration as recommended by the manufacturer, and all future experiments were performed
with this concentration of FCCP (1.0 nM).
Injection 1
Injection 2
Injection 3

Mito Stress Test
20 µl 10 µM Oligomycin (1.0 µM)
22 µl 10 µM FCCP (1.0 µM)
25 µl 5 µM Rotenone/Antimycin A (0.5 µM)

Glycolytic Stress Test
20 µl 100 mM Glucose (10 mM)
22 µl 10 µM Oligomycin (1.0 µM)
25 µl 500 mM 2-DG (50 mM)

Table 5: Volumes and concentrations of injections for Seahorse analysis, with final
concentrations in parentheses.
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Animals.
Mice with floxed endogenous NKA α1 isoform from Dr. Gustavo Blanco at Kansas
University Medical Center were crossed with FVB.Cg-Myod1tm2.1(icre)Glh/Jmice purchased
from Jackson Labs. Mice homozygous for floxed α1 (α1flox/flox) and heterozygous for
MyoDiCre (MyoDiCre/WT) were bred with α1flox/flox MyoDWT/WT mice, resulting in litters
of α1flox/flox MyoDiCre/WT (skα1-/-) mice with α1flox/flox MyoDWT/WT controls (skα1+/+).
Skα1-/- mice were born with the expected Mendelian frequency and appeared normal. Skα1-/mice and skα1+/+ control littermates were housed in 12-hour light and dark cycles at constant
temperature and humidity. All animal procedures were approved by the Marshall University
Institutional Animal Care and Use Committee.
pNaKtide diet study.
12-week-old male C57BL/6 mice were ordered from Jackson Labs and randomized to
receive normal chow + vehicle, Western diet (42% fat chow with 4.2g/L fructose water) +
vehicle, or Western diet + pNaKtide for 12 weeks. pNaKtide was dissolved in phosphatebuffered saline and administered via intraperitoneal injection every 2 days, while vehicle-treated
mice received phosphate-buffered saline via intraperitoneal injection every 2 days. Body
composition was measured using an Echo-MRI (EchoMRI, Houston, TX, USA). Tissues were
collected after 12 weeks of treatment and either fixed in 10% neutrally buffered formalin or flash
frozen in liquid nitrogen for future studies.
Treadmill testing.
12-week-old male and female skα1-/- mice and litter mate controls were placed in the six
lanes of an Exer 3/6 treadmill from Columbus Instruments equipped with a shock detection
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system. Animals were acclimated to the treadmill for 3 days at 5 m/min for 5 minutes at a 5°
angle and were subjected to the testing protocol on the fourth day. Mice began the testing
protocol running at 5 m/m for five minutes and increased by 2 m/min each minute up to 25
m/min, then continued running at 25 m/min until they reached fatigue. Each shock administered
and each visit to the shock grid was recorded for each animal. Fatigue was defined as 10
consecutive seconds spent on the shock grid, and the shock was discontinued to each mouse
upon reaching fatigue.
Gene
Mouse Actab
Mouse Rn18s
Mouse Ppargc1a
Mouse Atp5a1
Mouse Acadm
Mouse Hk2
Mouse Pkm
Mouse Pfkm
Mouse Nfe2l2
Mouse Hmox1
Mouse Nqo1
Mouse Gstm1
Mouse Ccl2
Mouse Tnfa
Mouse Il6
Mouse Il1b
Pig Gapdh
Pig Ppargc1a
Pig Atp5a1
Pig Acadm
Pig Hk2
Pig Pkm
Pig Pfkm

5’
5’
5'
5'
5'
5'
5'
5'
5’
5’
5’
5’
5’
5’
5'
5’
5'
5'
5'
5'
5'
5'
5'

Forward Sequence
GGCTGTATTCCCCTCCATCG 3’
CGAAAGCATTTGCCAAGAAT 3’
CAACAATGAGCCTGCGAACA 3'
CATTGGTGATGGTATTGCGC 3'
TGTTAATCGGTGAAGGAGCAG 3'
TTCGACCACATTGTCCAGTG 3'
CCATTCTCTACCGTCCTGTTG 3'
GATGGCTTTGAGGGTCTGG 3'
GGTTGCCCACATTCCCAAAC 3’
TGACACCTGAGGTCAAGCAC 3’
GGCCGATTCAGAGTGGCATC 3’
CTGACTTTGAGAAGCAGAAGCC 3’
TTTTGTCACCAAGCTCAAGAGA 3’
ATGGCCTCCCTCTCATCAGT 3’
TCCTCTCTGCAAGAGACTTCC 3'
TGCCACCTTTTGACAGTGATG 3’
GTGTCGGTTGTGGATCTGAC 3'
GCTTGACGAGCGTCATTCAG 3'
GCTGCAAAGATGCTGTCAGT 3'
AACCAGACCTTCGGTAGCAG 3'
GCCTGGCTAACTTCATGGAT 3'
TCATGCTGTCTGGAGAGACG 3'
CGTGTTAACCTCTGGTGGTG 3'

5’
5’
5'
5'
5'
5'
5'
5'
5’
5’
5’
5’
5’
5’
5'
5’
5'
5'
5'
5'
5'
5'
5'

Reverse Sequence
CCAGTTGGTAACAATGCCATGT 3’
AGTCGGCATCGTTTATGGTC 3’
CTTCATCCACGGGGAGACTG 3'
TCCCAAACACGACAACTCC 3'
CTATCCAGGGCATACTTCGTG 3'
CTTGAATCCCTTTGTCCACTTG 3'
TCCATGTAAGCGTTGTCCAG 3'
CTTGGTTATGTTGGCACTGATC 3'
TATCCAGGGCAAGCGACTCA 3’
GGCAGTATCTTGCACCAGGC 3’
CCAGACGGTTTCCAGACGTT 3’
TAGGTGTTGCGATGTAGCGG 3’
ATTAAGGCATCACAGTCCGAGT 3’
TGGTTTGCTACGACGTGGG 3’
TTGTGAAGTAGGGAAGGCCG 3'
AAGGTCCACGGGAAAGACAC 3’
CTGCTTCACCACCTTCTTGA 3'
AACCAGAGCAGCACACTCG 3'
AACAAAGGACGATCCCAAAG 3'
GCCATGTCAGCCAGCAAAAA 3'
CTGGACTTGAAACCCTTGGT 3'
GGCGGAGCTCCTCAAATAAT 3'
TGGTAACCCTCATGGACAAA 3'

Table 6: Primer sequences used in RT-qPCR.

Tissue collection.
Mice were anesthetized with 50 mg/kg pentobarbital administered via IP injection.
Tissues were dissected and weighed. Muscles used for Western blot analysis, qPCR, or
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enzymatic activity assays were flash frozen in liquid nitrogen then stored at -80° C until later
use. Muscles used for histological analysis were fixed in 10% neutrally buffered formalin for 24
hours then stored in 70% ethanol until they were embedded in paraffin blocks.
Western blot.
Left and right muscles of the same type from the same mouse were homogenized
together in ice-cold radioimmunoprecipitation (RIPA) buffer (0.25% sodium deoxycholate, 1%
Nonidet P-40, 1mM EDTA, 1mM PMSF, 1mM sodium orthovanadate, 1mM Sodium fluoride,
150 mM NaCl, 50 mM Tris-HCl, pH 7.4 and 1% protease inhibitor cocktail) with a Fisher
TissueMeiser homogenizer. Homogenates were centrifuged at 14,000 X g for 15 min,
supernatants were collected, and the protein content was measured using DC Protein Assay Kit
from BioRad (catalog number 500-0114 and 500-0113). Equal amounts of protein of each
sample were loaded, separated by SDS-PAGE, and transferred to nitrocellulose membranes.
Membranes probed for α1 and α2 were blocked in 5% milk, then primary antibodies were added
overnight at 4°C. Membranes were visualized with Western Lightning® Plus-ECL (Western
Lightning) and radiographic film. Densitometric quantification was performed using ImageJ
software from the National Institute of Health.
RT-qPCR.
RNA was extracted from tissues and cells using TRIzol Reagent (Life Technologies
Corporation, Carlsbad, CA, USA) according to manufacturer’s instructions. The amount and
quality of extracted RNA was measured using the Nanodrop 2000 (Thermo Scientific, Waltham,
MA, USA). SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Life Technologies
Corporation, Carlsbad, CA, USA) was used to synthesize first-strand cDNA. Gene expression
was analyzed by real-time quantitative RT-PCR using the LightCylcer 480 SYBR Green I
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Master mix (Roche, Indianapolis, IN, USA) using a LightCycler 480 Instrument II (Roche,
Indianapolis, IN, USA). Relative expression was calculated using the comparative Ct method
with data normalized to Actab (liver and skeletal muscle), Rn18s (adipose), or Gapdh (AAC-19,
LX-α2, and LY-a2 cell lines) as previously described (Livak & Schmittgen, 2001). Primer
sequences are listed in Table S3.
RNA sequencing and data analysis.
RNA was extracted from whole gastrocnemius muscles using a combination of TRIzol
Reagent (Life Technologies Corporation, Carlsbad, CA, USA) and an RNeasy kit (Qiagen,
Hillden, Germany) the method described by Bhatnagar, Panguluri, and Kumar (2012). RNA
sequencing was performed by Novogene (Sacramento, CA, USA). A heatmap of the top 70
differential expressed genes were visualized by log2 normalized fragments per kilobase million
(Fpkm), using cytoscape 3.7.1 (Shannon et al., 2003) and clusterMaker2 (Morris et al., 2011).
Gene Ontology (GO) enrichment were analyzed using BiNGO (Maere, Heymans, & Kuiper,
2005), and then visualized using EnrichmentMap (Merico, Isserlin, Stueker, Emili, & Bader,
2010).
Membrane fractionation.
Crude membrane fractions were prepared from frozen α1+/- and α1+/+ gastrocnemius
muscles following a procedure modified from Walas and Juel (Walas & Juel, 2012). Frozen
muscles were ground into a fine powder with a mortar and pestle. The resulting powder was
homogenized in ice-cold fractionation buffer (250 mM mannitol, 30 mM L-histidine, 5 mM
EGTA and 0.1% deoxycholate, adjusted to pH 6.8 with Tris-base) for 30 seconds with a Fisher
Tissue Meiser handheld homogenizer. The crude homogenate was centrifuged at 3000xg for 30
minutes and the supernatant was then centrifuged at 190,000xg for 90 minutes. The pellet was
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resuspended in 30 mM histidine, 250 mM sucrose, and 1 mM EDTA, pH 7.4, and protein
concentration was determined using the DC Protein Assay Kit from BioRad (catalog number
500-0114 and 500-0113).
ATPase activity assay.
Ouabain-sensitive ATPase activity in crude membrane fractions was determined by
measuring ATP hydrolysis as previously described (Belliard et al., 2016; Belliard et al., 2013).
Released inorganic phosphate (Pi) was detected using a malachite-based Biomol Green reagent.
Samples containing 10 µg of protein were added to a reaction mix containing 20 mM Tris-HCL,
1 mM MgCl2, 100 mM NaCl, 20 mM KCl, and 1 mM EGTA-Tris, pH 7.2. Ouabain was added
to the samples to a final concentration of 1 mM to completely inhibit both α1 and α2 isoforms of
the NKA. After 10 minutes of preincubation at room temperature, the reaction was started by
adding Mg-ATP at a final concentration of 2.25 mM and incubation at 37°C with shaking for 30
minutes. The reaction was stopped with the addition of ice-cold 8% TCA, and the concentration
of Pi was measured spectrophotometrically at OD 620 nm using Biomol Green as an indicator
(Enzo Life Sciences catalog # BML-AK111-250). Maximal NKA activity was calculated as the
difference between ATPase activity obtained in the absence or presence of 1 mM ouabain.
Immunohistochemistry.
Muscles were collected and then washed twice with ice-cold PBS, fixed with 10%
neutrally buffered formalin for 24 hours, and embedded in paraffin. Transverse sections of the
midbelly were immunostained for myosin heavy chain (Myhc) fast and Myhc slow by Wax-It,
Inc., as described by Behan et al. (Behan et al., 2002) to differentiate between type 1 and type 2
fibers. Additional sections were stained for NKA α1 by Wax-It, Inc. (Vancouver, Canada). The
samples were examined on a Leica confocal SP5 microscope (Leica Microsystems, Wetzlar,
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Germany). The images were processed with the Leica Application Suite Advanced Fluorescence
(LAS/AF) suite (Leica Microsystems, Wetzlar, Germany), FIJI platform, and the GNU Image
Manipulation Program (GIMP) to obtain maximum projections, extract lateral slices, and
construct figures.
Morphometric tissue analysis (CSA and fiber types).
Images of muscles stained for fast and slow myosin heavy chain were obtained by WaxIt, Inc. with digital whole-slide scanning. Aperio ImageScope software was used to determine the
cross sectional area (CSA) of each fiber. Fibers that had been damaged were excluded from CSA
analysis. Every fiber of each type in each muscle was counted to determine the average number
of fibers per muscle.
Western diet study.
6-8-week-old male mice were placed on a 42% fat diet with 4.2g/L fructose water with
controls on a normal chow diet for 12 weeks. Glucose tolerance tests were performed at 6 weeks
and insulin tolerance tests were performed at 12 weeks. Tissues were collected and weighed after
12 weeks of diet treatment, and flash frozen in liquid nitrogen or fixed in 10% neutrally buffered
formalin for 24 hours then transferred to 70% ethanol for shipment to Wax-It, Inc., for paraffin
embedding and hematoxylin and eosin staining.
pNaKtide diet study.
12-week-old male C57BL/6 mice were ordered from Jackson Labs and randomized to
receive normal chow + vehicle, Western diet (42% fat chow with 4.2g/L fructose water) +
vehicle, or Western diet + pNaKtide for 12 weeks. pNaKtide was dissolved in phosphatebuffered saline and administered via intraperitoneal injection every 2 days, while vehicle-treated
mice received phosphate-buffered saline via intraperitoneal injection every 2 days. Body
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composition was measured using an Echo-MRI (EchoMRI, Houston, TX, USA). Tissues were
dissected and flash frozen in liquid N2 for biochemical analysis or fixed in 10% neutrally
buffered formalin for histological analysis.
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CHAPTER 4
DISCUSSION AND CONCLUSIONS
Isoform-specific role of NKA α1 in skeletal muscle
These studies reveal that the NKA α1 isoform has an isoform-specific role in skeletal
muscle that cannot be filled by the α2 isoform, in spite of its low expression as a proportion of
the total NKA pool in skeletal muscle (He et al., 2001). While NKA α2 is indeed vital for normal
contractility (DiFranco et al., 2015; Radzyukevich et al., 2013), the skeletal muscle-specific
ablation of α2 has no impact on skeletal muscle growth. In contrast, our skα1-/- mice had a 35%
decrease in muscle mass and abnormal muscle structure (Figure 17), revealing that the growth of
skeletal muscle is regulated by NKA α1 in an isoform-specific manner. Similarly, no clear
metabolic defects were described in skeletal muscles lacking NKA α2, although the studies of
the role of α2 in skeletal muscle did not specifically evaluate markers of altered metabolism
(DiFranco et al., 2015; Manoharan et al., 2015; Radzyukevich et al., 2013).
Additionally, the treadmill running studies reported by Radzyukevich et al. (2013) reveal
a severe defect in running ability in mice with a skeletal muscle-specific ablation of α2 which is
absent in skα1-/- mice (Figure 18). This further confirms the isoform specificity of the
‘turbocharger’ role of NKA α2 in maintaining the membrane potential during muscle
contraction, as ablation of NKA α1 did not impact running even at speeds of 25 meters per
minute but did impact endurance, which is associated with metabolic defects rather than ion
transport defect.
NKA α1 regulates muscle growth
One of the most striking results of these studies is the impact of a reduction or ablation of
NKA α1 on muscle growth. While this was the first time that a direct relationship between NKA
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α1 and skeletal muscle growth was reported, a similar role for α1 in growth regulation has been
shown in other models, including renal epithelial cell growth and cardiomyocyte proliferation in
vitro (Huang et al., 1997; Liu et al., 2006; Tian et al., 2009; J. Xie et al., 2015; Z. Xie et al.,
1999) and renal development in vivo (Fontana et al., 2013). While the exact mechanism of that
regulation was not clarified in this body of work, the importance of the Src binding site for the
ability of NKA α1 to regulate cell proliferation has been established in other models (Lai et al.,
2013; Yu et al., 2018). Additionally, NKA α1 signaling in skeletal muscle cells has been linked
to Src- and Erk-mediated GSK3β inactivation (Kotova, Al-Khalili, et al., 2006; Kotova, Galuska,
et al., 2006). Inactivation of GSK3β, in turn, has been linked to myogenesis and the growth of
skeletal muscles (Agley et al., 2017; Leger et al., 2006; van der Velden et al., 2007), while the
activation of GSK3β is associated with skeletal muscle atrophy (Verhees et al., 2011; W. Yang et
al., 2007).
The possibility that GSK3β is involved is compelling, but it cannot fully explain the
skα1-/- phenotype. The α1+/- model had decreased muscle mass in spite of apparently normal
GSK3β expression (Figure 8), suggesting that the growth defects in this model of reduced NKA
α1 expression was not mediated by GSK3β. Furthermore, the impact of altered GSK3β
expression are much smaller than the effects of altered NKA α1 expression, even when paired
with altered GSK3α expression to eliminate compensation by the other isoform. This suggests
that the skα1-/- phenotype is mediated by multiple pathways, of which GSK3β is merely one.
The fact that the ablation of the dominant α2 isoform does not have the same impact on skeletal
muscle growth supports the hypothesis that mechanism by which α1 regulates skeletal muscle
growth and development is independent of ion pumping (DiFranco et al., 2015; Manoharan et al.,
2015; Radzyukevich et al., 2013).
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Another possible mechanism by which α1 could regulate myogenesis is via the Wnt
signaling pathway. The caveolin binding motif of α1 has been shown to regulate embryonic
organogenesis via Wnt/β-catenin signaling, and although myogenesis was not specifically
evaluated, this process represents a possible mechanism for the regulation of muscle growth by
NKA α1. Although this hypothesis is compelling, additional studies are necessary to understand
which aspects of muscle development are impacted, such as the cardiotoxin method of evaluating
muscle growth and repair (Garry, Antony, & Garry, 2016; Guardiola et al., 2017) or in vitro
studies of myoblast proliferation and differentiation.
NKA α1 regulates muscle metabolism
Previous studies have found links between NKA activity and metabolic control of
glycolysis, both under physiological and pathological conditions (Banerjee et al., 2018; J. H.
James et al., 1996; J. H. James et al., 1999; Lynch & Balaban, 1987a, 1987b; Okamoto et al.,
2001; Sepp et al., 2014). This set of studies is unique in that it identified a direct link between the
NKA α1 isoform and regulation of metabolic flexibility and spare capacity, both key components
of skeletal muscle metabolism. The decrease in oxidative muscle size observed in α1+/- mice
(Figure 5) and the switch from oxidative to glycolytic fibers in skα1-/- mice (Figure 16) both
suggest decreased metabolic flexibility when NKA α1 expression is decreased or ablated. The
functional importance of this metabolic regulation is supported by the lack of endurance
exhibited by skα1-/- mice when subjected to forced treadmill running (Figure 18). However, this
metabolic flexibility appears to come at the cost of intolerance to a Western diet (Figures 19-20).
Furthermore, our studies with renal epithelial-derived cell lines expressing Src binding-mutant
α1 and α2 suggest that this link is mediated by the α1-specific NKA/Src interaction.
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This regulation of skeletal muscle metabolism by the NKA α1/Src signaling complex has
implications for our understanding of exercise-induced metabolic adaptations and skeletal
muscle hypertrophy. Exercise has been shown to increase circulating levels of endogenous
cardiotonic steroids (Bauer et al., 2005), but what role this spike in NKA ligands plays in
physiological adaptations to exercise has not been explored. The generation of mice with
ouabain-resistant NKA α2 revealed that increased circulating ouabain during exercise reduces
exercise capacity due to reduced ion transport (Radzyukevich et al., 2009). However, in light of
these new revelations about the role of NKA α1-mediated signaling in skeletal muscle growth
and metabolism, the possibility that increased circulating cardiotonic steroids during exercise
could stimulate NKA α1/Src signaling and thereby mediate skeletal muscle metabolic responses
to exercise should be investigated. The metabolic adaptations to exercise training in several
existing animals, such as global α1 haplodeficient mice, skeletal muscle-specific α1 knockout
mice, and mice expressing ouabain sensitive α1, could be evaluated and contrasted to determine
what role endogenous ouabain signaling through NKA α1 plays in exercise-induced metabolic
adaptations. Additionally, generation of a mouse model with a skeletal muscle-specific rescue of
α1 expression with a signaling-null α1, such as the A420P mutant used in Figure 14, would allow
us to differentiate between the ion transport function and the Src-mediated signaling function of
NKA α1 in skeletal muscle.
Evolutionary implications
If this novel role of NKA α1 in skeletal muscle is in fact mediated by Src signaling, it
could indicate the evolution of a novel regulator of metabolic flexibility and metabolism in
mammals and birds that is not seen in other classes of animals. The convergent evolution of the
NaKtide sequence in birds and mammals is intriguing, especially with the metabolic phenotype
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observed in A420P cells, which have a conserved Y260 region and disrupted Src binding only in
the NaKtide region. Unlike the LX-α2 cells which have no Src binding capacity and have
decreased basal mitochondrial metabolism and unchanged basal glycolytic metabolism (Figure
13), A420P cells have unchanged basal mitochondrial metabolism and increased basal glycolytic
metabolism (Figure 67). This suggests that the acquisition of the NaKtide region alone is enough
to increase basal metabolism, which according to the aerobic scope hypothesis was a key
component of the development of endothermy (Clarke & Pörtner, 2010; Nespolo et al., 2017).
For these reasons, the evolutionary implications of the Src binding capacity of NKA α1 in
endotherms bear further investigation.
Additionally, the metabolic reserve and flexibility afforded by Src binding appear to
come at the cost of intolerance to nutritional oversupply. Based on the work done by Sodhi et al,
NKA signaling through Src appears to facilitate adipogenesis and the storage of lipids, as well as
the development of T2D (Sodhi et al., 2015; Sodhi et al., 2018). Administration of pNaKtide, a
small peptide inhibitor of NKA-mediated Src activation based on the NaKtide sequence,
prevents the development of metabolic syndrome on a Western diet and attenuates aging (Sodhi
et al., 2015; Sodhi et al., 2018). These affects are attributed to the disruption of the ROSmediated feed-forward NKA α1 activation loop (Yan et al., 2013).
Similarly, skα1-/- mice which lack this signaling pathway and subsequent metabolic
control are resistant to the metabolic effects of the Western diet (Figures 19-20). This resistance
does not come without a price. Indeed, under normal, healthy conditions, these mice exhibit
decreased exercise performance and display multiple hallmarks of decreased metabolic
flexibility and increased metabolic dysfunction, including a severe decrease in endurance
exercise tolerance (Figure 18), a switch to more glycolytic fibers (Figure 16), and decreased
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glycogen storage (Figure 18). Therefore, we can hypothesize that the addition of this new
mechanism for regulating metabolism may also have introduced a mechanism by which
metabolism can become dysregulated, resulting in metabolic disease.
Clinical implications
These studies provide the first genetic evidence of NKA α1 as an important regulator of
metabolism in vivo. Although previous studies using pNaKtide have linked NKA α1 signaling to
metabolism and metabolic disorders (J. Liu et al., 2016; Sodhi et al., 2015; Sodhi et al., 2018;
Sodhi et al., 2017; Srikanthan et al., 2016), it is possible that pNaKtide may have off-target
effects on Src independent of NKA α1 itself. Additionally, these studies involved the systemic
disruption of the NKA α1/Src signaling complex, which makes it difficult to identify the specific
impact of altered NKA α1/Src signaling on individual tissues. Furthermore, the identification of
NKA as a regulator of metabolic flexibility in skeletal muscle could lead to the development of
novel treatments for metabolic disorders which target the NKA/Src signaling axis, or to the
application of existing drugs such as digoxin that are capable of targeting NKA for a different
therapeutic goal.
Additionally, the identification of NKA as a regulator of skeletal muscle growth is
similarly useful in treating muscle wasting due to cachexia, sarcopenia, and disuse by stimulating
NKA signaling through Src, thereby increasing the activation of key growth pathways and
increasing muscle mass and metabolic flexibility. Moreover, because NKA signaling contributes
to the regulation of both metabolism and growth in skeletal muscle, it could be a useful
therapeutic goal for populations who are in need of addressing both muscle wasting and
metabolism, such as elderly patients suffering from type 2 diabetes in addition to sarcopenia, or
patients with burn cachexia whose muscle metabolism can be controlled with CTS which can
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also contribute to increasing muscle growth and decreasing wasting (Dhillon & Hasni, 2017;
Pedroso et al., 2012; Sakuma et al., 2017). Furthermore, if exercise-induced increases in
metabolic flexibility and mitochondrial metabolism are mediated by increased circulating
cardiotonic steroids which increase NKA α1 signaling through Src in skeletal muscle, it may be
possible to mimic the health benefits of exercise pharmacologically using exogenous cardiotonic
steroids for those who are unable to exercise, such as patients on bedrest.
The striking impact of NKA α1 ablation on skeletal muscle size and morphology
provides compelling evidence that NKA α1 signaling regulates skeletal muscle growth and
development. However, without identifying the specific aspects of skeletal muscle development
that are impacted, it is difficult to recognize which developmental and degenerative muscle
conditions might benefit from the pharmacological targeting of this pathway. The commonly
used cardiotoxin injury model of skeletal muscle regeneration could provide insight into the
aspects of skeletal muscle growth and differentiation that are mediated by NKA α1 and could
identify the muscle wasting conditions that are most likely to benefit from NKA α1-targeted
therapeutics. Additionally, the viability of such therapeutic options should be validated using
animal models of muscle wasting diseases such as the hindlimb suspension model of disuseinduced atrophy, the mdx mouse model of Duchenne’s muscular dystrophy, and the cancer
cachexia model in tumor-inoculated immunodeficient mice.
While differences in α1 expression have been identified in multiple disease states, we
have yet to evaluate the impacts of genetically altering α1 expression in other tissues. Whether
altered α1 expression contributes to the progression of these diseases or is a protective
mechanism is also unclear. The skα1-/- mice were protected from Western diet-induced
metabolic dysfunction (Figures 20 and 21), suggesting that although NKA α1 plays a vital role in

87

the development of normal metabolism in skeletal muscle, it also plays a key role in the
pathological dysregulation of metabolism. Given that metabolism is dysregulated in many of the
diseases in which α1 expression is altered, including heart failure (L. Liu et al., 2016), diabetic
neuropathy (Gerbi et al., 1998), and polycystic ovarian syndrome (Tepavcevic et al., 2015),
reduced expression of NKA α1 may actually be protective as the loss of the NKA α1/Src
signaling complex appears to be protective in our model. These studies of the interaction
between skeletal muscle-specific NKA α1 ablation and Western diet-induced metabolic
dysregulation are intriguing and bring up the possibility that ablation of the NKA/Src receptor
complex in other tissues in other disease states could enhance our understanding of the
interaction of this signaling mechanism and human disease, thus leading to further uses of NKA
α1 as a pharmacological target. This is supported by the similarities between the effects of α1
ablation and treatment with pNaKtide to ‘short circuit’ Src signaling.
Limitations
One mechanism that these studies fail to address is the impact of NKA α1 ablation on
calcium signaling, which is critical in skeletal muscle (Hostrup et al., 2014). Additionally, while
the effects we see with decreased or ablated NKA expression in skeletal muscle are consistent
with the effects of the disruption of NKA α1/Src signaling complex in other cell types in vitro
(Banerjee et al., 2018; Lai et al., 2013; J. Xie et al., 2015; Yu et al., 2018), we did not perform
experiments that specifically interrupted this complex in skeletal muscle. To do this, a system of
signaling-null rescue of NKA α1 expression would be ideal.
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APPENDIX B
ABBREVIATIONS
µg – micrograms; 1/1000000th of a gram
2-DG – 2-deoxyglucose
AAC-19 – porcine renal epithelial cell line
Akt – protein kinase B (see also: PKB)
AMP – adenosine monophosphate
AMPK – 5’ adenosine monophosphate-activated protein kinase
ANOVA – analysis of variance
ATCC – American Type Culture Collection
ATP – adenosine triphosphate
ATP1A1 – Na/K-ATPase α1
AUC – area under the curve
BiNGO – Biological Networks Gene Ontology tool
B-Raf – serine/threonine-protein kinase B-Raf
BW – body weight
C2C12 – immortalized mouse myoblast line
C57J/Bl6 – commonly used strain of inbred mice
cAMP – cyclic adenosine monophosphate
cDNA – complementary deoxyribonucleic acid
CSA – cross-sectional area
CTS – cardiotonic steroids
DIO2 – type II iodothyronine deiodinase
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DMEM – Dulbecco’s modified Eagle’s medium
ECAR – extracellular acidification rate
ECL – enhanced chemiluminescence
EDL – extensor digitorum longus
EDTA – ethylenediaminetetraacetic acid
EGF – epidermal growth factor
EGFR – epidermal growth factor receptor
EGTA – ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acidethylene
FBS – fetal bovine serum
FCCP – carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone
FIJI – FIJI is just ImageJ
FVB – albino inbred mouse strain
FXYD1 – phospholemman
GIMP – GNU image manipulation program
GLUT4 – glucose transporter type 4
GSK-3β – glycogen synthase kinase 3β
GTT – glucose tolerance test
IP – intraperitoneal
IP3 – inositol triphosphate
ITT – insulin tolerance test
K+ – potassium
KCl – potassium chloride
LAS/AF – Leica Application Suite/Advanced Fluorescence
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LX-α2 – LLC-PK1-derived cell line
LY-a2 – LLC-PK1-derived cell line
m/min – meters per minute
MAPK – mitogen-activated protein kinase
mg/g – milligram/gram
mg/kg – milligram/kilogram
Mg-ATP – magnesium adenosine triphosphate
MgCl2 – magnesium chloride
MIIR – Marshall Institute for Interdisciplinary Research
mM – millimolar; millimoles per liter
MRF4 – myogenic factor 6; herculin
mRNA – messenger ribonucleic acid
mTORC – mammalian target of rapamycin complex
Myhc – myosin heavy chain
Na/K-ATPase – sodium-potassium adenosine triphosphatase (see also: NKA)
Na+ – sodium
NaCl – sodium chloride
NAD(P)H – nicotinamide adenine dinucleotide phosphate and nicotinamide adenine
dinucleotide
NADPH – nicotinamide adenine dinucleotide phosphate
NaKtide – peptide based on Src binding site in ATP1A1
NASH – non-alcoholic steatohepatitis
NC – normal chow
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NFAT – nuclear factor of activated T-cells
NF-κB – nuclear factor kappa-light-chain-enhancer of activated B cells
NIH – National Institute of Health
NKA – sodium-potassium adenosine triphosphatase (see also: Na/K-ATPase)
nm – nanometer
Nrf2 – nuclear factor erythroid 2-related factor 2
OCR – oxygen consumption rate
OD – optical density
PBS – phosphate-buffered saline
PGC-1α – peroxisome proliferator-activated receptor gamma coactivator-1α
Pi – inorganic phosphate
PI3K – phosphoinositide 3-kinase
PKA – protein kinase A
PMSF – phenylmethylsulfonyl fluoride
PPARγ – peroxisome proliferator-activated receptor gamma
p-Ser9 – phosphorylated serine 9
PY-17 – LLC-PK1-derived cell line
qPCR – quantitative polymerase chain reaction (see also: qRT-PCR, RT-PCR)
qRT-PCR – quantitative real time polymerase chain reaction (see also: qPCR, RTPCR)
R Gastroc – red gastrocnemius muscle
Rap1 – Ras-proximate-1 or Ras-related-protein-1
RIPA – radioimmunoprecipitation assay
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RNA – ribonucleic acid
ROS – reactive oxygen species
RT – reverse transcriptase
RT-PCR – real-time polymerase chain reaction (see also: qPCR, qRT-PCR)
SDS-PAGE – sodium dodecyl sulfate–polyacrylamide gel electrophoresis
SEM – standard error of the mean
skα1-/- – skeletal muscle-specific ATP1A1 knockout mouse
Src – proto-oncogene tyrosine-protein kinase Src
SST-MINI tubes – serum separator miniature tubes
SubQ – subcutaneous
T3 – triiodothyronine
T4 – thyroxine
TCA – tricarboxylic acid
Tris-HCl – tris(hydroxymethyl)aminomethane hydrochloride
W Gastroc – white gastrocnemius muscle
WD – Western diet
xg – times gravitational force
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